Gene Symbol | Gene ID | Gene Info |
---|---|---|
Sox2
|
ENSMUSG00000074637.4 | SRY (sex determining region Y)-box 2 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr3_34649198_34650117 | Sox2 | 748 | 0.503632 | 0.82 | 1.0e-14 | Click! |
chr3_34650209_34650435 | Sox2 | 83 | 0.947031 | 0.82 | 2.5e-14 | Click! |
chr3_34650777_34651154 | Sox2 | 560 | 0.624757 | 0.81 | 9.8e-14 | Click! |
chr3_34648225_34648376 | Sox2 | 2105 | 0.189031 | 0.80 | 2.0e-13 | Click! |
chr3_34647874_34648037 | Sox2 | 2450 | 0.168082 | 0.75 | 5.9e-11 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr3_108433472_108434154 | 44.23 |
Gm22942 |
predicted gene, 22942 |
7517 |
0.09 |
chr6_89613728_89614091 | 40.85 |
Chchd6 |
coiled-coil-helix-coiled-coil-helix domain containing 6 |
18257 |
0.17 |
chr9_41697271_41698297 | 39.86 |
Gm48784 |
predicted gene, 48784 |
22730 |
0.14 |
chr10_106609605_106610022 | 37.36 |
4930532I03Rik |
RIKEN cDNA 4930532I03 gene |
7333 |
0.29 |
chr12_3236518_3237725 | 37.30 |
Rab10os |
RAB10, member RAS oncogene family, opposite strand |
510 |
0.74 |
chr14_66494473_66494955 | 35.86 |
Gm23899 |
predicted gene, 23899 |
96981 |
0.07 |
chr3_40070102_40070729 | 33.85 |
Gm42785 |
predicted gene 42785 |
246838 |
0.02 |
chr3_16819324_16819513 | 33.19 |
Gm26485 |
predicted gene, 26485 |
3894 |
0.38 |
chr3_127294086_127294512 | 33.16 |
Gm42970 |
predicted gene 42970 |
5374 |
0.15 |
chr1_172349913_172350109 | 32.97 |
Kcnj10 |
potassium inwardly-rectifying channel, subfamily J, member 10 |
8801 |
0.11 |
chr15_66239660_66240017 | 32.89 |
Kcnq3 |
potassium voltage-gated channel, subfamily Q, member 3 |
46213 |
0.14 |
chr4_3082761_3083956 | 31.55 |
Vmn1r-ps2 |
vomeronasal 1 receptor, pseudogene 2 |
21234 |
0.18 |
chr3_19406344_19406802 | 31.36 |
Pde7a |
phosphodiesterase 7A |
95251 |
0.07 |
chr7_31149516_31150411 | 30.97 |
G630030J09Rik |
RIKEN cDNA G630030J09 gene |
435 |
0.6 |
chr13_54874229_54874840 | 30.90 |
Gm29431 |
predicted gene 29431 |
12936 |
0.13 |
chr8_65617940_65618821 | 30.67 |
Marchf1 |
membrane associated ring-CH-type finger 1 |
145 |
0.97 |
chr8_12947304_12948554 | 30.51 |
Mcf2l |
mcf.2 transforming sequence-like |
10 |
0.49 |
chr4_122998402_122999232 | 29.82 |
Mycl |
v-myc avian myelocytomatosis viral oncogene lung carcinoma derived |
63 |
0.96 |
chr12_98573417_98573836 | 29.34 |
Kcnk10 |
potassium channel, subfamily K, member 10 |
1086 |
0.43 |
chr6_22794374_22794759 | 28.89 |
Gm25942 |
predicted gene, 25942 |
4748 |
0.17 |
chr14_68981312_68981674 | 28.60 |
Stc1 |
stanniocalcin 1 |
47745 |
0.13 |
chr16_90522093_90522383 | 28.59 |
Gm36001 |
predicted gene, 36001 |
28371 |
0.14 |
chr3_158062143_158062492 | 28.54 |
Lrrc40 |
leucine rich repeat containing 40 |
39 |
0.97 |
chr4_72233972_72234136 | 28.38 |
C630043F03Rik |
RIKEN cDNA C630043F03 gene |
32706 |
0.18 |
chr6_81660570_81661025 | 28.04 |
Gm26264 |
predicted gene, 26264 |
22486 |
0.22 |
chr17_88494469_88494803 | 27.89 |
Ppp1r21 |
protein phosphatase 1, regulatory subunit 21 |
35482 |
0.13 |
chr6_54554355_54554906 | 27.73 |
Scrn1 |
secernin 1 |
175 |
0.95 |
chr4_22301616_22301795 | 27.72 |
Gm11882 |
predicted gene 11882 |
25872 |
0.19 |
chr3_56955404_56955772 | 27.53 |
Gm22269 |
predicted gene, 22269 |
98562 |
0.08 |
chr14_54332194_54332698 | 27.34 |
Gm3945 |
predicted gene 3945 |
1771 |
0.19 |
chr10_29143551_29143727 | 27.30 |
Soga3 |
SOGA family member 3 |
200 |
0.8 |
chr10_29143863_29144732 | 26.80 |
Gm9996 |
predicted gene 9996 |
103 |
0.69 |
chr3_17796321_17796503 | 26.62 |
Mir124-2hg |
Mir124-2 host gene (non-protein coding) |
668 |
0.46 |
chr10_108133791_108134149 | 26.52 |
Gm47999 |
predicted gene, 47999 |
8462 |
0.25 |
chr15_91018414_91018934 | 26.50 |
Kif21a |
kinesin family member 21A |
31144 |
0.16 |
chr9_36821327_36821662 | 26.40 |
Fez1 |
fasciculation and elongation protein zeta 1 (zygin I) |
370 |
0.82 |
chrX_143543266_143543620 | 26.00 |
Pak3 |
p21 (RAC1) activated kinase 3 |
24745 |
0.25 |
chr1_78190714_78190948 | 26.00 |
Pax3 |
paired box 3 |
6007 |
0.24 |
chr2_152048577_152049360 | 25.87 |
AA387200 |
expressed sequence AA387200 |
27840 |
0.11 |
chr16_16561093_16561486 | 25.85 |
Fgd4 |
FYVE, RhoGEF and PH domain containing 4 |
1070 |
0.53 |
chr9_13652356_13652901 | 25.73 |
Maml2 |
mastermind like transcriptional coactivator 2 |
9832 |
0.2 |
chr13_85773910_85774095 | 25.71 |
Gm47636 |
predicted gene, 47636 |
91331 |
0.09 |
chr15_73021189_73021788 | 25.66 |
Trappc9 |
trafficking protein particle complex 9 |
34322 |
0.18 |
chr3_66325480_66326023 | 25.23 |
Veph1 |
ventricular zone expressed PH domain-containing 1 |
28914 |
0.18 |
chr9_10269473_10269801 | 25.22 |
Gm24496 |
predicted gene, 24496 |
20950 |
0.22 |
chr2_93891393_93892295 | 24.95 |
Accsl |
1-aminocyclopropane-1-carboxylate synthase (non-functional)-like |
22687 |
0.14 |
chr6_63911299_63911450 | 24.93 |
Gm44075 |
predicted gene, 44075 |
127307 |
0.05 |
chr18_15544080_15544457 | 24.87 |
Aqp4 |
aquaporin 4 |
133286 |
0.05 |
chr3_128546488_128546865 | 24.77 |
Gm22293 |
predicted gene, 22293 |
6304 |
0.29 |
chr2_141074597_141074768 | 24.54 |
Macrod2 |
mono-ADP ribosylhydrolase 2 |
50620 |
0.15 |
chr11_32157683_32158170 | 24.52 |
Gm12109 |
predicted gene 12109 |
27079 |
0.12 |
chr5_33995599_33996957 | 24.25 |
Nat8l |
N-acetyltransferase 8-like |
294 |
0.82 |
chr2_53437450_53438022 | 23.94 |
Gm13501 |
predicted gene 13501 |
39249 |
0.2 |
chr16_33605736_33606716 | 23.92 |
Slc12a8 |
solute carrier family 12 (potassium/chloride transporters), member 8 |
9599 |
0.26 |
chr10_80300858_80301038 | 23.85 |
Apc2 |
APC regulator of WNT signaling pathway 2 |
86 |
0.91 |
chr2_152050523_152051049 | 23.76 |
AA387200 |
expressed sequence AA387200 |
26022 |
0.12 |
chr10_81364518_81366962 | 23.76 |
4930404N11Rik |
RIKEN cDNA 4930404N11 gene |
50 |
0.91 |
chr6_55920513_55920755 | 23.66 |
Itprid1 |
ITPR interacting domain containing 1 |
33809 |
0.21 |
chr14_16200666_16200873 | 23.54 |
Rpl31-ps3 |
ribosomal protein L31, pseudogene 3 |
24254 |
0.13 |
chrX_42361720_42361910 | 23.47 |
Gm14619 |
predicted gene 14619 |
14303 |
0.27 |
chr1_68047124_68047492 | 23.41 |
Gm15671 |
predicted gene 15671 |
23065 |
0.22 |
chr6_144313023_144313448 | 23.39 |
Sox5 |
SRY (sex determining region Y)-box 5 |
103667 |
0.08 |
chr10_108701445_108701650 | 23.35 |
Gm5136 |
predicted gene 5136 |
1387 |
0.53 |
chr4_3067329_3068553 | 23.34 |
Gm27878 |
predicted gene, 27878 |
16122 |
0.2 |
chr17_52601056_52601789 | 23.25 |
Gm27217 |
predicted gene 27217 |
1238 |
0.39 |
chr15_84417749_84418106 | 23.23 |
Shisal1 |
shisa like 1 |
25770 |
0.18 |
chr5_37245988_37246869 | 23.23 |
Crmp1 |
collapsin response mediator protein 1 |
583 |
0.76 |
chr3_108409761_108410771 | 23.14 |
Celsr2 |
cadherin, EGF LAG seven-pass G-type receptor 2 |
5286 |
0.1 |
chr12_44403738_44404185 | 23.10 |
Gm48182 |
predicted gene, 48182 |
5829 |
0.21 |
chr8_123411336_123412017 | 23.06 |
Tubb3 |
tubulin, beta 3 class III |
86 |
0.91 |
chr14_70659174_70659883 | 22.92 |
Npm2 |
nucleophosmin/nucleoplasmin 2 |
284 |
0.85 |
chr17_52602043_52602770 | 22.89 |
Gm27217 |
predicted gene 27217 |
254 |
0.55 |
chr3_17785697_17785901 | 22.79 |
Mir124-2hg |
Mir124-2 host gene (non-protein coding) |
4122 |
0.22 |
chr13_77892438_77892993 | 22.62 |
Pou5f2 |
POU domain class 5, transcription factor 2 |
132187 |
0.05 |
chr12_26802654_26802851 | 22.54 |
4933409F18Rik |
RIKEN cDNA 4933409F18 gene |
32107 |
0.23 |
chr14_66319706_66319909 | 22.53 |
Gm41183 |
predicted gene, 41183 |
21422 |
0.13 |
chr2_174917610_174917806 | 22.50 |
Gm14616 |
predicted gene 14616 |
61419 |
0.09 |
chr2_126015456_126015651 | 22.49 |
Fgf7 |
fibroblast growth factor 7 |
19105 |
0.23 |
chr12_80061788_80062584 | 22.46 |
Gm36660 |
predicted gene, 36660 |
19248 |
0.14 |
chr11_32087496_32088333 | 22.43 |
Gm12108 |
predicted gene 12108 |
13314 |
0.2 |
chr7_79497714_79498195 | 22.23 |
Mir9-3hg |
Mir9-3 host gene |
2072 |
0.16 |
chr2_17730264_17731671 | 22.22 |
Nebl |
nebulette |
76 |
0.98 |
chr19_33049205_33049364 | 22.15 |
Gm29863 |
predicted gene, 29863 |
20788 |
0.21 |
chr7_84409236_84410328 | 22.02 |
Arnt2 |
aryl hydrocarbon receptor nuclear translocator 2 |
101 |
0.96 |
chr10_127078401_127078887 | 22.02 |
Agap2 |
ArfGAP with GTPase domain, ankyrin repeat and PH domain 2 |
263 |
0.78 |
chr4_107835452_107835981 | 22.01 |
Lrp8 |
low density lipoprotein receptor-related protein 8, apolipoprotein e receptor |
4731 |
0.12 |
chr5_52516049_52516436 | 22.01 |
Gm43685 |
predicted gene 43685 |
22589 |
0.13 |
chr13_57603438_57603669 | 22.01 |
Spock1 |
sparc/osteonectin, cwcv and kazal-like domains proteoglycan 1 |
304034 |
0.01 |
chr18_49770746_49771045 | 22.00 |
Gm16283 |
predicted gene 16283 |
15101 |
0.18 |
chr7_97446538_97446946 | 21.82 |
Kctd14 |
potassium channel tetramerisation domain containing 14 |
4581 |
0.16 |
chr8_70119396_70119618 | 21.79 |
Ncan |
neurocan |
1366 |
0.21 |
chr8_90741015_90741332 | 21.75 |
Gm35850 |
predicted gene, 35850 |
398 |
0.82 |
chr7_64533404_64533751 | 21.72 |
Gm44721 |
predicted gene 44721 |
4152 |
0.22 |
chr5_124334425_124334781 | 21.70 |
2810006K23Rik |
RIKEN cDNA 2810006K23 gene |
6505 |
0.11 |
chr9_26518773_26519056 | 21.62 |
Gm30313 |
predicted gene, 30313 |
31039 |
0.22 |
chr13_83749857_83750036 | 21.58 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
11083 |
0.12 |
chr4_97649219_97649597 | 21.37 |
E130114P18Rik |
RIKEN cDNA E130114P18 gene |
41328 |
0.18 |
chr3_13470653_13471071 | 21.35 |
Ralyl |
RALY RNA binding protein-like |
793 |
0.48 |
chr6_103558666_103559112 | 21.32 |
Gm44441 |
predicted gene, 44441 |
5467 |
0.16 |
chr4_22835787_22836371 | 21.28 |
Gm24078 |
predicted gene, 24078 |
88948 |
0.09 |
chr15_8781624_8782079 | 21.26 |
Slc1a3 |
solute carrier family 1 (glial high affinity glutamate transporter), member 3 |
71087 |
0.11 |
chr18_33890616_33890776 | 21.24 |
Epb41l4a |
erythrocyte membrane protein band 4.1 like 4a |
943 |
0.66 |
chr15_58976304_58977052 | 21.17 |
Mtss1 |
MTSS I-BAR domain containing 1 |
4139 |
0.18 |
chr11_32383714_32384390 | 21.09 |
Sh3pxd2b |
SH3 and PX domains 2B |
36212 |
0.13 |
chr6_47239363_47240145 | 21.07 |
Cntnap2 |
contactin associated protein-like 2 |
4633 |
0.33 |
chr4_32923442_32923826 | 21.06 |
Ankrd6 |
ankyrin repeat domain 6 |
129 |
0.96 |
chr5_146592655_146592919 | 21.02 |
Gm34333 |
predicted gene, 34333 |
7315 |
0.13 |
chr9_52223852_52224218 | 20.92 |
Zc3h12c |
zinc finger CCCH type containing 12C |
55463 |
0.12 |
chr10_79874050_79875052 | 20.91 |
Plppr3 |
phospholipid phosphatase related 3 |
19 |
0.53 |
chr19_17492246_17492464 | 20.85 |
Rfk |
riboflavin kinase |
94918 |
0.08 |
chr1_42686778_42686966 | 20.82 |
Pantr1 |
POU domain, class 3, transcription factor 3 adjacent noncoding transcript 1 |
6221 |
0.15 |
chr15_24567016_24567356 | 20.75 |
Gm48920 |
predicted gene, 48920 |
38292 |
0.19 |
chr15_25364173_25365245 | 20.64 |
4930445E18Rik |
RIKEN cDNA 4930445E18 gene |
32050 |
0.14 |
chr4_141335224_141335761 | 20.63 |
Gm25690 |
predicted gene, 25690 |
10672 |
0.09 |
chr7_79590405_79591230 | 20.52 |
Gm45169 |
predicted gene 45169 |
1796 |
0.2 |
chr19_21789708_21790094 | 20.51 |
Cemip2 |
cell migration inducing hyaluronidase 2 |
11513 |
0.21 |
chr3_139885937_139886924 | 20.48 |
Gm43678 |
predicted gene 43678 |
73666 |
0.11 |
chr18_81251894_81252538 | 20.46 |
Gm30192 |
predicted gene, 30192 |
12475 |
0.22 |
chr13_71148802_71148994 | 20.46 |
Mir466f-4 |
microRNA 466f-4 |
41809 |
0.19 |
chr8_12486572_12486996 | 20.45 |
4933439N14Rik |
RIKEN cDNA 4933439N14 gene |
16115 |
0.15 |
chr4_82690701_82691000 | 20.37 |
Gm11269 |
predicted gene 11269 |
1955 |
0.35 |
chr7_49018514_49018702 | 20.34 |
Gm45207 |
predicted gene 45207 |
43973 |
0.12 |
chr2_146324969_146325239 | 20.31 |
Gm14117 |
predicted gene 14117 |
19557 |
0.21 |
chr14_93009566_93009910 | 20.28 |
Gm48963 |
predicted gene, 48963 |
117036 |
0.06 |
chr11_88585153_88585378 | 20.27 |
Msi2 |
musashi RNA-binding protein 2 |
4882 |
0.29 |
chr11_58948518_58949018 | 20.19 |
H2bu2 |
H2B.U histone 2 |
152 |
0.86 |
chr15_67245652_67245820 | 20.15 |
1700012I11Rik |
RIKEN cDNA 1700012I11 gene |
18967 |
0.26 |
chr8_45508006_45508255 | 20.14 |
Sorbs2 |
sorbin and SH3 domain containing 2 |
212 |
0.94 |
chr12_44329338_44330111 | 20.12 |
Nrcam |
neuronal cell adhesion molecule |
474 |
0.8 |
chr10_20285369_20285909 | 20.11 |
Gm48249 |
predicted gene, 48249 |
987 |
0.4 |
chr13_8333561_8334203 | 20.09 |
Gm48260 |
predicted gene, 48260 |
34739 |
0.14 |
chr18_62868650_62868901 | 20.08 |
Gm50128 |
predicted gene, 50128 |
53326 |
0.12 |
chr6_61042953_61043250 | 20.04 |
Gm43892 |
predicted gene, 43892 |
1892 |
0.33 |
chr7_4123736_4124170 | 20.01 |
Ttyh1 |
tweety family member 1 |
536 |
0.57 |
chr12_86787306_86787470 | 19.94 |
Lrrc74a |
leucine rich repeat containing 74A |
46381 |
0.11 |
chr7_62416271_62416450 | 19.93 |
Mkrn3 |
makorin, ring finger protein, 3 |
3779 |
0.19 |
chr18_26753599_26753876 | 19.90 |
Gm49976 |
predicted gene, 49976 |
164360 |
0.04 |
chr13_71690114_71690396 | 19.88 |
Gm47812 |
predicted gene, 47812 |
65227 |
0.12 |
chr6_86028659_86028835 | 19.87 |
Add2 |
adducin 2 (beta) |
0 |
0.96 |
chr8_48458356_48458774 | 19.81 |
Tenm3 |
teneurin transmembrane protein 3 |
96748 |
0.08 |
chr13_84783122_84783632 | 19.81 |
Gm26913 |
predicted gene, 26913 |
92436 |
0.09 |
chr12_116919674_116920700 | 19.71 |
Gm48119 |
predicted gene, 48119 |
67085 |
0.14 |
chr14_79773979_79774403 | 19.70 |
Pcdh8 |
protocadherin 8 |
2879 |
0.2 |
chr13_12650037_12651101 | 19.65 |
Gpr137b-ps |
G protein-coupled receptor 137B, pseudogene |
181 |
0.91 |
chr13_113918235_113918418 | 19.64 |
Arl15 |
ADP-ribosylation factor-like 15 |
123704 |
0.05 |
chr2_180854971_180855595 | 19.61 |
Gm14339 |
predicted gene 14339 |
7631 |
0.11 |
chr2_76029370_76029626 | 19.51 |
Pde11a |
phosphodiesterase 11A |
23455 |
0.18 |
chr4_39345030_39345334 | 19.50 |
Gm23607 |
predicted gene, 23607 |
49719 |
0.14 |
chr14_24617341_24617911 | 19.48 |
4930428N03Rik |
RIKEN cDNA 4930428N03 gene |
58 |
0.64 |
chr13_83868824_83869019 | 19.47 |
2810049E08Rik |
RIKEN cDNA 2810049E08 gene |
22287 |
0.18 |
chr18_67497794_67498327 | 19.38 |
Spire1 |
spire type actin nucleation factor 1 |
331 |
0.86 |
chr13_83885160_83885448 | 19.24 |
2810049E08Rik |
RIKEN cDNA 2810049E08 gene |
5904 |
0.23 |
chr11_14181939_14182516 | 19.15 |
4930554G24Rik |
RIKEN cDNA 4930554G24 gene |
3186 |
0.33 |
chr5_85239463_85240008 | 19.15 |
Gm21006 |
predicted gene, 21006 |
372890 |
0.01 |
chr14_70076721_70076985 | 19.05 |
Egr3 |
early growth response 3 |
350 |
0.85 |
chr8_47218091_47218404 | 19.02 |
Stox2 |
storkhead box 2 |
1946 |
0.35 |
chr4_57091378_57091763 | 19.01 |
Epb41l4b |
erythrocyte membrane protein band 4.1 like 4b |
11883 |
0.23 |
chr12_111693687_111693960 | 18.97 |
Gm36635 |
predicted gene, 36635 |
9259 |
0.09 |
chrX_13346707_13347908 | 18.96 |
Gm7129 |
predicted gene 7129 |
20288 |
0.14 |
chr15_103519338_103519794 | 18.95 |
Pde1b |
phosphodiesterase 1B, Ca2+-calmodulin dependent |
4152 |
0.16 |
chr13_42709847_42710338 | 18.95 |
Phactr1 |
phosphatase and actin regulator 1 |
511 |
0.85 |
chr8_35933319_35934071 | 18.91 |
Gm22030 |
predicted gene, 22030 |
43883 |
0.13 |
chr2_22029112_22029317 | 18.90 |
Gm13337 |
predicted gene 13337 |
38612 |
0.22 |
chr4_12263404_12263560 | 18.88 |
Gm11846 |
predicted gene 11846 |
7917 |
0.21 |
chr3_102979946_102980141 | 18.87 |
Sike1 |
suppressor of IKBKE 1 |
15665 |
0.12 |
chr14_7749491_7749764 | 18.81 |
Gm16741 |
predicted gene, 16741 |
318 |
0.87 |
chr1_132739219_132739652 | 18.79 |
Nfasc |
neurofascin |
2322 |
0.3 |
chr8_86385246_86385589 | 18.73 |
Gm24490 |
predicted gene, 24490 |
92916 |
0.08 |
chr14_118416177_118416529 | 18.70 |
Gm5672 |
predicted gene 5672 |
40159 |
0.12 |
chr12_111758304_111760062 | 18.67 |
Klc1 |
kinesin light chain 1 |
170 |
0.91 |
chr3_55373721_55374118 | 18.61 |
Dclk1 |
doublecortin-like kinase 1 |
19785 |
0.15 |
chr1_63819909_63820082 | 18.59 |
Gm13751 |
predicted gene 13751 |
25583 |
0.16 |
chr14_78383257_78383728 | 18.56 |
Gm26197 |
predicted gene, 26197 |
72152 |
0.09 |
chr10_108580885_108581405 | 18.53 |
Syt1 |
synaptotagmin I |
55819 |
0.14 |
chr16_77787854_77788233 | 18.50 |
Gm17333 |
predicted gene, 17333 |
58561 |
0.11 |
chr5_53525618_53525873 | 18.50 |
Gm10441 |
predicted gene 10441 |
3014 |
0.26 |
chr5_44537719_44537895 | 18.46 |
Ldb2 |
LIM domain binding 2 |
2710 |
0.2 |
chr6_55791826_55792546 | 18.43 |
Itprid1 |
ITPR interacting domain containing 1 |
44709 |
0.18 |
chr9_66933818_66934187 | 18.42 |
Rps27l |
ribosomal protein S27-like |
12084 |
0.15 |
chr2_131847315_131847793 | 18.36 |
5330413P13Rik |
RIKEN cDNA 5330413P13 gene |
69 |
0.93 |
chr4_100973634_100974412 | 18.32 |
Cachd1 |
cache domain containing 1 |
20588 |
0.19 |
chr2_63273724_63274213 | 18.27 |
Kcnh7 |
potassium voltage-gated channel, subfamily H (eag-related), member 7 |
89681 |
0.09 |
chr13_18281120_18281485 | 18.26 |
Pou6f2 |
POU domain, class 6, transcription factor 2 |
94816 |
0.08 |
chr1_82474542_82474693 | 18.18 |
Gm28940 |
predicted gene 28940 |
71871 |
0.08 |
chr18_25378079_25378424 | 18.17 |
Gm16558 |
predicted gene 16558 |
13550 |
0.27 |
chr8_92134225_92134404 | 18.16 |
Gm45332 |
predicted gene 45332 |
23952 |
0.17 |
chr9_84033065_84033577 | 18.14 |
Bckdhb |
branched chain ketoacid dehydrogenase E1, beta polypeptide |
2519 |
0.29 |
chrX_143654722_143655126 | 18.11 |
Pak3 |
p21 (RAC1) activated kinase 3 |
9366 |
0.3 |
chr14_119513370_119513775 | 18.11 |
Gm6212 |
predicted gene 6212 |
130440 |
0.05 |
chr14_103764083_103764411 | 18.10 |
Slain1os |
SLAIN motif family, member 1, opposite strand |
64805 |
0.11 |
chr2_165136026_165136418 | 18.08 |
Gm14397 |
predicted gene 14397 |
23190 |
0.14 |
chr2_21010740_21011090 | 18.07 |
Gm13375 |
predicted gene 13375 |
41861 |
0.14 |
chr15_78835129_78836581 | 18.05 |
Cdc42ep1 |
CDC42 effector protein (Rho GTPase binding) 1 |
6769 |
0.09 |
chr16_77400634_77400819 | 17.99 |
Gm21816 |
predicted gene, 21816 |
121 |
0.94 |
chr14_64489462_64489613 | 17.97 |
Msra |
methionine sulfoxide reductase A |
33634 |
0.16 |
chr3_138854704_138854876 | 17.95 |
Tspan5 |
tetraspanin 5 |
5703 |
0.23 |
chr13_51229149_51229565 | 17.93 |
Gm29787 |
predicted gene, 29787 |
23246 |
0.14 |
chr18_27956389_27956743 | 17.92 |
Gm33674 |
predicted gene, 33674 |
146834 |
0.05 |
chr14_24618263_24618731 | 17.92 |
4930428N03Rik |
RIKEN cDNA 4930428N03 gene |
534 |
0.66 |
chr10_52877516_52878175 | 17.90 |
Gm25664 |
predicted gene, 25664 |
27793 |
0.18 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
18.4 | 55.3 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
12.7 | 38.2 | GO:0003358 | noradrenergic neuron development(GO:0003358) |
11.5 | 45.9 | GO:0060486 | Clara cell differentiation(GO:0060486) |
10.5 | 31.5 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
9.3 | 28.0 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
9.3 | 37.0 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
9.2 | 55.1 | GO:0045631 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
9.0 | 27.1 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
8.7 | 26.0 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
8.3 | 25.0 | GO:0070649 | formin-nucleated actin cable assembly(GO:0070649) |
7.8 | 46.5 | GO:1904424 | regulation of GTP binding(GO:1904424) |
7.6 | 84.0 | GO:0048505 | regulation of timing of cell differentiation(GO:0048505) |
7.5 | 37.3 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
7.1 | 28.6 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
6.9 | 20.7 | GO:0060594 | mammary gland specification(GO:0060594) |
6.9 | 27.6 | GO:0060221 | retinal rod cell differentiation(GO:0060221) |
6.8 | 20.5 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
6.8 | 47.8 | GO:0045161 | neuronal ion channel clustering(GO:0045161) |
6.6 | 19.9 | GO:0051586 | positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
6.5 | 6.5 | GO:0035910 | ascending aorta development(GO:0035905) ascending aorta morphogenesis(GO:0035910) |
6.4 | 19.1 | GO:0060448 | dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
6.3 | 6.3 | GO:0035973 | aggrephagy(GO:0035973) |
6.2 | 6.2 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
6.2 | 24.8 | GO:0036135 | Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
6.1 | 18.2 | GO:1904956 | regulation of midbrain dopaminergic neuron differentiation(GO:1904956) |
6.0 | 6.0 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
6.0 | 18.1 | GO:0071873 | response to norepinephrine(GO:0071873) |
6.0 | 6.0 | GO:0061000 | negative regulation of dendritic spine development(GO:0061000) |
6.0 | 23.9 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
5.8 | 35.0 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
5.7 | 34.4 | GO:0016198 | axon choice point recognition(GO:0016198) |
5.7 | 17.2 | GO:0015746 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
5.6 | 22.5 | GO:0006538 | glutamate catabolic process(GO:0006538) |
5.6 | 16.8 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
5.6 | 11.2 | GO:0021827 | cerebral cortex tangential migration using cell-cell interactions(GO:0021823) postnatal olfactory bulb interneuron migration(GO:0021827) |
5.6 | 44.4 | GO:0021860 | pyramidal neuron development(GO:0021860) |
5.5 | 22.2 | GO:0030035 | microspike assembly(GO:0030035) |
5.5 | 121.6 | GO:0007026 | negative regulation of microtubule depolymerization(GO:0007026) |
5.4 | 10.9 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
5.4 | 21.7 | GO:0007412 | axon target recognition(GO:0007412) |
5.4 | 27.0 | GO:0042297 | vocal learning(GO:0042297) imitative learning(GO:0098596) learned vocalization behavior or vocal learning(GO:0098598) |
5.3 | 42.6 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
5.3 | 21.2 | GO:1901841 | regulation of high voltage-gated calcium channel activity(GO:1901841) |
5.2 | 10.4 | GO:0097091 | synaptic vesicle clustering(GO:0097091) |
5.2 | 5.2 | GO:0046865 | retinol transport(GO:0034633) isoprenoid transport(GO:0046864) terpenoid transport(GO:0046865) |
5.1 | 10.2 | GO:2000302 | positive regulation of synaptic vesicle exocytosis(GO:2000302) |
5.1 | 25.4 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
5.1 | 10.1 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
5.0 | 20.0 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
5.0 | 54.5 | GO:0097120 | receptor localization to synapse(GO:0097120) |
4.9 | 14.6 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
4.8 | 14.5 | GO:1900368 | regulation of RNA interference(GO:1900368) |
4.8 | 14.3 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
4.7 | 19.0 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) |
4.7 | 14.2 | GO:0021564 | vagus nerve development(GO:0021564) |
4.7 | 14.0 | GO:2000667 | positive regulation of interleukin-5 secretion(GO:2000664) positive regulation of interleukin-13 secretion(GO:2000667) |
4.6 | 23.1 | GO:0071699 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
4.6 | 27.6 | GO:0035881 | amacrine cell differentiation(GO:0035881) |
4.6 | 13.8 | GO:0061743 | motor learning(GO:0061743) |
4.6 | 13.7 | GO:0061551 | cerebral cortex tangential migration using cell-axon interactions(GO:0021824) substrate-dependent cerebral cortex tangential migration(GO:0021825) gonadotrophin-releasing hormone neuronal migration to the hypothalamus(GO:0021828) hypothalamic tangential migration using cell-axon interactions(GO:0021856) trigeminal ganglion development(GO:0061551) facioacoustic ganglion development(GO:1903375) |
4.6 | 13.7 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
4.5 | 4.5 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
4.5 | 4.5 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
4.5 | 8.9 | GO:0046101 | hypoxanthine metabolic process(GO:0046100) hypoxanthine biosynthetic process(GO:0046101) |
4.5 | 17.9 | GO:0007258 | JUN phosphorylation(GO:0007258) |
4.5 | 13.4 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
4.4 | 8.8 | GO:0061642 | chemoattraction of axon(GO:0061642) |
4.4 | 13.1 | GO:0061366 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
4.2 | 12.7 | GO:1904058 | positive regulation of sensory perception of pain(GO:1904058) |
4.2 | 8.4 | GO:2001016 | positive regulation of skeletal muscle cell differentiation(GO:2001016) |
4.2 | 33.4 | GO:0046069 | cGMP catabolic process(GO:0046069) |
4.1 | 12.4 | GO:0019244 | lactate biosynthetic process from pyruvate(GO:0019244) lactate biosynthetic process(GO:0019249) |
4.1 | 40.5 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
4.0 | 28.3 | GO:0042473 | outer ear morphogenesis(GO:0042473) |
4.0 | 8.1 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
4.0 | 12.1 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
4.0 | 12.0 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
3.9 | 11.8 | GO:0097503 | sialylation(GO:0097503) |
3.9 | 11.8 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
3.8 | 11.4 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
3.8 | 15.1 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
3.8 | 7.5 | GO:0090027 | negative regulation of monocyte chemotaxis(GO:0090027) |
3.8 | 11.3 | GO:0098910 | regulation of atrial cardiac muscle cell action potential(GO:0098910) |
3.7 | 7.5 | GO:1900825 | regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900825) |
3.7 | 7.4 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) |
3.7 | 14.8 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
3.7 | 18.4 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
3.6 | 14.6 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
3.6 | 7.3 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
3.6 | 58.2 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
3.6 | 47.2 | GO:0007096 | regulation of exit from mitosis(GO:0007096) |
3.6 | 14.5 | GO:0046959 | habituation(GO:0046959) |
3.6 | 10.9 | GO:0046103 | inosine biosynthetic process(GO:0046103) |
3.6 | 7.2 | GO:0003357 | noradrenergic neuron differentiation(GO:0003357) |
3.6 | 10.7 | GO:0046684 | response to pyrethroid(GO:0046684) |
3.5 | 24.8 | GO:2000009 | negative regulation of protein localization to cell surface(GO:2000009) |
3.5 | 42.4 | GO:0048268 | clathrin coat assembly(GO:0048268) |
3.5 | 7.0 | GO:0097360 | chorionic trophoblast cell proliferation(GO:0097360) regulation of chorionic trophoblast cell proliferation(GO:1901382) |
3.5 | 17.5 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
3.5 | 51.9 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
3.4 | 6.9 | GO:0060166 | olfactory pit development(GO:0060166) |
3.4 | 10.2 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
3.4 | 6.8 | GO:0035262 | gonad morphogenesis(GO:0035262) |
3.4 | 6.8 | GO:1904861 | excitatory synapse assembly(GO:1904861) |
3.4 | 10.2 | GO:0048677 | axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
3.4 | 10.1 | GO:2001170 | negative regulation of ATP biosynthetic process(GO:2001170) |
3.4 | 10.1 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
3.4 | 3.4 | GO:1902896 | terminal web assembly(GO:1902896) |
3.3 | 23.2 | GO:0071625 | vocalization behavior(GO:0071625) |
3.3 | 9.9 | GO:0051466 | positive regulation of corticotropin-releasing hormone secretion(GO:0051466) |
3.2 | 9.7 | GO:0030070 | insulin processing(GO:0030070) |
3.2 | 9.7 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
3.2 | 28.9 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
3.2 | 6.4 | GO:0072318 | clathrin coat disassembly(GO:0072318) |
3.2 | 9.5 | GO:0034184 | positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
3.1 | 9.4 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
3.1 | 9.4 | GO:0001998 | angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001998) |
3.1 | 3.1 | GO:0003100 | regulation of systemic arterial blood pressure by endothelin(GO:0003100) |
3.1 | 3.1 | GO:0071435 | potassium ion export(GO:0071435) |
3.1 | 27.5 | GO:0035418 | protein localization to synapse(GO:0035418) |
3.0 | 9.1 | GO:0061577 | calcium ion transmembrane transport via high voltage-gated calcium channel(GO:0061577) |
2.9 | 8.8 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
2.9 | 8.8 | GO:0090310 | negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
2.9 | 14.5 | GO:0022038 | corpus callosum development(GO:0022038) |
2.9 | 17.4 | GO:0048840 | otolith development(GO:0048840) |
2.9 | 8.6 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
2.9 | 8.6 | GO:0097154 | GABAergic neuron differentiation(GO:0097154) |
2.9 | 5.7 | GO:0089700 | protein kinase D signaling(GO:0089700) |
2.8 | 90.4 | GO:0019228 | neuronal action potential(GO:0019228) |
2.8 | 19.8 | GO:0042118 | endothelial cell activation(GO:0042118) |
2.8 | 14.0 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
2.8 | 11.2 | GO:0021830 | interneuron migration from the subpallium to the cortex(GO:0021830) |
2.8 | 5.6 | GO:0043435 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
2.8 | 11.1 | GO:0023041 | neuronal signal transduction(GO:0023041) |
2.8 | 8.3 | GO:0046881 | positive regulation of follicle-stimulating hormone secretion(GO:0046881) |
2.8 | 8.3 | GO:0032512 | regulation of protein phosphatase type 2B activity(GO:0032512) |
2.7 | 24.7 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
2.7 | 5.4 | GO:0051665 | membrane raft localization(GO:0051665) |
2.7 | 8.0 | GO:0008228 | opsonization(GO:0008228) |
2.7 | 8.0 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
2.7 | 5.3 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
2.6 | 23.8 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
2.6 | 7.8 | GO:1902564 | negative regulation of neutrophil activation(GO:1902564) |
2.6 | 7.7 | GO:1900242 | regulation of synaptic vesicle endocytosis(GO:1900242) |
2.6 | 10.3 | GO:1901386 | negative regulation of voltage-gated calcium channel activity(GO:1901386) |
2.6 | 25.8 | GO:0072311 | renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
2.6 | 7.7 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
2.6 | 5.1 | GO:1901740 | negative regulation of myoblast fusion(GO:1901740) |
2.5 | 10.2 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
2.5 | 2.5 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
2.5 | 2.5 | GO:0098597 | observational learning(GO:0098597) |
2.5 | 5.1 | GO:0034091 | regulation of maintenance of sister chromatid cohesion(GO:0034091) regulation of maintenance of mitotic sister chromatid cohesion(GO:0034182) |
2.5 | 2.5 | GO:0097104 | postsynaptic membrane assembly(GO:0097104) |
2.5 | 15.1 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
2.5 | 7.5 | GO:0097476 | motor neuron migration(GO:0097475) spinal cord motor neuron migration(GO:0097476) |
2.5 | 10.0 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
2.5 | 42.5 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
2.5 | 20.0 | GO:0034776 | response to histamine(GO:0034776) cellular response to histamine(GO:0071420) |
2.5 | 27.4 | GO:0050966 | detection of mechanical stimulus involved in sensory perception of pain(GO:0050966) |
2.5 | 10.0 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
2.5 | 2.5 | GO:0033602 | negative regulation of dopamine secretion(GO:0033602) |
2.5 | 4.9 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
2.5 | 7.4 | GO:0060437 | lung growth(GO:0060437) |
2.5 | 22.1 | GO:0008038 | neuron recognition(GO:0008038) |
2.4 | 7.2 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
2.4 | 7.2 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
2.4 | 9.6 | GO:0001927 | exocyst assembly(GO:0001927) |
2.4 | 7.2 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) |
2.4 | 23.9 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
2.4 | 2.4 | GO:0003330 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
2.3 | 4.7 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
2.3 | 11.6 | GO:1903071 | positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
2.3 | 6.9 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
2.3 | 9.2 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
2.3 | 4.6 | GO:1901536 | regulation of DNA demethylation(GO:1901535) negative regulation of DNA demethylation(GO:1901536) |
2.3 | 11.4 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
2.3 | 6.8 | GO:0071694 | protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
2.2 | 8.9 | GO:0010042 | response to manganese ion(GO:0010042) |
2.2 | 8.9 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
2.2 | 2.2 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
2.2 | 4.5 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
2.2 | 15.6 | GO:0060013 | righting reflex(GO:0060013) |
2.2 | 22.1 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
2.2 | 8.8 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
2.2 | 8.8 | GO:0060278 | regulation of ovulation(GO:0060278) |
2.2 | 13.2 | GO:0072178 | nephric duct development(GO:0072176) nephric duct morphogenesis(GO:0072178) |
2.2 | 4.4 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
2.2 | 24.0 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
2.2 | 2.2 | GO:0001661 | conditioned taste aversion(GO:0001661) |
2.2 | 15.2 | GO:1904321 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
2.2 | 6.5 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
2.2 | 13.0 | GO:0060997 | dendritic spine morphogenesis(GO:0060997) |
2.2 | 2.2 | GO:0060523 | prostate epithelial cord elongation(GO:0060523) |
2.2 | 8.6 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
2.1 | 14.9 | GO:0051764 | actin crosslink formation(GO:0051764) |
2.1 | 6.4 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
2.1 | 2.1 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
2.1 | 2.1 | GO:0060371 | regulation of atrial cardiac muscle cell membrane depolarization(GO:0060371) |
2.1 | 6.2 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
2.1 | 10.4 | GO:0008354 | germ cell migration(GO:0008354) |
2.1 | 6.2 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
2.1 | 4.1 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
2.1 | 10.3 | GO:0019227 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
2.1 | 6.2 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
2.0 | 30.4 | GO:0060074 | synapse maturation(GO:0060074) |
2.0 | 4.0 | GO:2001027 | negative regulation of endothelial cell chemotaxis(GO:2001027) |
2.0 | 2.0 | GO:0097212 | lysosomal membrane organization(GO:0097212) |
2.0 | 4.0 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
2.0 | 2.0 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
2.0 | 3.9 | GO:0019230 | proprioception(GO:0019230) |
2.0 | 7.8 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
2.0 | 7.8 | GO:0018406 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
1.9 | 7.8 | GO:1900864 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
1.9 | 9.7 | GO:0010996 | response to auditory stimulus(GO:0010996) |
1.9 | 5.8 | GO:2001025 | positive regulation of response to drug(GO:2001025) |
1.9 | 7.7 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
1.9 | 5.8 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
1.9 | 11.5 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
1.9 | 13.4 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
1.9 | 11.4 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
1.9 | 3.8 | GO:1903261 | regulation of serine phosphorylation of STAT3 protein(GO:1903261) |
1.9 | 3.8 | GO:0060266 | negative regulation of respiratory burst involved in inflammatory response(GO:0060266) |
1.9 | 5.7 | GO:0048239 | negative regulation of DNA recombination at telomere(GO:0048239) regulation of DNA recombination at telomere(GO:0072695) |
1.9 | 3.8 | GO:0035635 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
1.9 | 1.9 | GO:0021544 | subpallium development(GO:0021544) striatum development(GO:0021756) |
1.9 | 14.9 | GO:0007191 | adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
1.9 | 3.7 | GO:0021530 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
1.8 | 3.7 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
1.8 | 11.1 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
1.8 | 1.8 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
1.8 | 20.2 | GO:0060384 | innervation(GO:0060384) |
1.8 | 9.1 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) |
1.8 | 7.3 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
1.8 | 25.3 | GO:0003417 | growth plate cartilage development(GO:0003417) |
1.8 | 9.0 | GO:0032229 | negative regulation of synaptic transmission, GABAergic(GO:0032229) |
1.8 | 1.8 | GO:1904181 | positive regulation of membrane depolarization(GO:1904181) |
1.8 | 1.8 | GO:0048807 | female genitalia morphogenesis(GO:0048807) |
1.8 | 5.4 | GO:0098828 | modulation of inhibitory postsynaptic potential(GO:0098828) |
1.8 | 1.8 | GO:1905005 | regulation of epithelial to mesenchymal transition involved in endocardial cushion formation(GO:1905005) |
1.8 | 19.5 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
1.8 | 1.8 | GO:0090427 | activation of meiosis(GO:0090427) |
1.8 | 3.5 | GO:0071673 | positive regulation of smooth muscle cell chemotaxis(GO:0071673) |
1.8 | 5.3 | GO:0061590 | calcium activated phospholipid scrambling(GO:0061588) calcium activated phosphatidylserine scrambling(GO:0061589) calcium activated phosphatidylcholine scrambling(GO:0061590) calcium activated galactosylceramide scrambling(GO:0061591) |
1.8 | 7.0 | GO:0014028 | notochord formation(GO:0014028) |
1.8 | 12.3 | GO:0021542 | dentate gyrus development(GO:0021542) |
1.8 | 3.5 | GO:0021794 | thalamus development(GO:0021794) |
1.7 | 1.7 | GO:0030432 | peristalsis(GO:0030432) |
1.7 | 5.2 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
1.7 | 3.5 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
1.7 | 5.2 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
1.7 | 5.2 | GO:0044828 | negative regulation by host of viral genome replication(GO:0044828) |
1.7 | 1.7 | GO:0048936 | peripheral nervous system neuron axonogenesis(GO:0048936) |
1.7 | 1.7 | GO:1900377 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
1.7 | 5.1 | GO:0014724 | regulation of twitch skeletal muscle contraction(GO:0014724) |
1.7 | 13.7 | GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
1.7 | 5.1 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
1.7 | 3.4 | GO:0007386 | compartment pattern specification(GO:0007386) |
1.7 | 3.4 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
1.7 | 3.3 | GO:0003150 | muscular septum morphogenesis(GO:0003150) |
1.7 | 1.7 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
1.7 | 8.3 | GO:0018230 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
1.7 | 1.7 | GO:1904259 | regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
1.7 | 6.6 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
1.7 | 9.9 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
1.6 | 3.3 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
1.6 | 4.9 | GO:0032430 | positive regulation of phospholipase A2 activity(GO:0032430) |
1.6 | 8.1 | GO:1904587 | glycoprotein ERAD pathway(GO:0097466) response to glycoprotein(GO:1904587) |
1.6 | 8.1 | GO:0015808 | L-alanine transport(GO:0015808) |
1.6 | 24.2 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
1.6 | 19.2 | GO:0001964 | startle response(GO:0001964) |
1.6 | 8.0 | GO:0046543 | development of secondary female sexual characteristics(GO:0046543) |
1.6 | 3.2 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
1.6 | 3.2 | GO:0032058 | positive regulation of translational initiation in response to stress(GO:0032058) |
1.6 | 6.3 | GO:0030091 | protein repair(GO:0030091) |
1.6 | 1.6 | GO:0072172 | ureteric bud formation(GO:0060676) mesonephric tubule formation(GO:0072172) |
1.6 | 40.6 | GO:0021954 | central nervous system neuron development(GO:0021954) |
1.6 | 3.1 | GO:0030421 | defecation(GO:0030421) |
1.6 | 4.7 | GO:0046544 | development of secondary male sexual characteristics(GO:0046544) |
1.6 | 12.4 | GO:0015816 | glycine transport(GO:0015816) |
1.6 | 4.7 | GO:2000195 | negative regulation of female gonad development(GO:2000195) |
1.5 | 4.6 | GO:0003344 | pericardium morphogenesis(GO:0003344) |
1.5 | 4.6 | GO:0070366 | regulation of hepatocyte differentiation(GO:0070366) |
1.5 | 15.3 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
1.5 | 3.0 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
1.5 | 6.0 | GO:0016584 | nucleosome positioning(GO:0016584) |
1.5 | 4.5 | GO:0071492 | cellular response to UV-A(GO:0071492) |
1.5 | 25.2 | GO:0050650 | chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
1.5 | 5.9 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) |
1.5 | 2.9 | GO:0021912 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) |
1.5 | 4.4 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
1.5 | 10.3 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
1.5 | 23.4 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
1.5 | 10.2 | GO:0046851 | negative regulation of bone remodeling(GO:0046851) |
1.5 | 5.8 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
1.4 | 1.4 | GO:1904017 | response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
1.4 | 1.4 | GO:0045726 | positive regulation of integrin biosynthetic process(GO:0045726) |
1.4 | 52.4 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
1.4 | 2.8 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
1.4 | 12.6 | GO:0060044 | negative regulation of cardiac muscle cell proliferation(GO:0060044) |
1.4 | 8.4 | GO:0060004 | reflex(GO:0060004) |
1.4 | 2.7 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
1.4 | 5.4 | GO:0010587 | miRNA catabolic process(GO:0010587) |
1.4 | 4.1 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
1.4 | 14.9 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
1.3 | 5.4 | GO:0048003 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
1.3 | 1.3 | GO:1904023 | fermentation(GO:0006113) glucose catabolic process to lactate(GO:0019659) glycolytic fermentation(GO:0019660) glucose catabolic process to lactate via pyruvate(GO:0019661) regulation of fermentation(GO:0043465) regulation of NAD metabolic process(GO:1902688) regulation of glucose catabolic process to lactate via pyruvate(GO:1904023) |
1.3 | 2.6 | GO:2001054 | negative regulation of mesenchymal cell apoptotic process(GO:2001054) |
1.3 | 7.8 | GO:0001504 | neurotransmitter uptake(GO:0001504) |
1.3 | 9.1 | GO:0060736 | prostate gland growth(GO:0060736) |
1.3 | 2.6 | GO:0070253 | somatostatin secretion(GO:0070253) |
1.3 | 3.9 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
1.3 | 36.2 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
1.3 | 6.4 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
1.3 | 2.5 | GO:0014049 | positive regulation of glutamate secretion(GO:0014049) |
1.3 | 20.1 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
1.3 | 2.5 | GO:0072093 | metanephric renal vesicle formation(GO:0072093) |
1.3 | 5.0 | GO:1903887 | motile primary cilium assembly(GO:1903887) |
1.3 | 12.5 | GO:0060749 | mammary gland alveolus development(GO:0060749) mammary gland lobule development(GO:0061377) |
1.2 | 3.7 | GO:0030157 | pancreatic juice secretion(GO:0030157) |
1.2 | 2.5 | GO:2000211 | regulation of glutamate metabolic process(GO:2000211) |
1.2 | 7.5 | GO:0015074 | DNA integration(GO:0015074) |
1.2 | 5.0 | GO:0021895 | cerebral cortex neuron differentiation(GO:0021895) |
1.2 | 2.5 | GO:2000019 | negative regulation of male gonad development(GO:2000019) |
1.2 | 16.1 | GO:0035640 | exploration behavior(GO:0035640) |
1.2 | 2.5 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
1.2 | 2.5 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
1.2 | 2.5 | GO:0090135 | actin filament branching(GO:0090135) |
1.2 | 1.2 | GO:2000412 | thymocyte migration(GO:0072679) regulation of thymocyte migration(GO:2000410) positive regulation of thymocyte migration(GO:2000412) |
1.2 | 1.2 | GO:0060125 | negative regulation of growth hormone secretion(GO:0060125) |
1.2 | 1.2 | GO:0003180 | aortic valve development(GO:0003176) aortic valve morphogenesis(GO:0003180) |
1.2 | 3.6 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
1.2 | 3.6 | GO:0008090 | retrograde axonal transport(GO:0008090) |
1.2 | 8.4 | GO:0044387 | negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
1.2 | 15.5 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
1.2 | 4.8 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
1.2 | 4.7 | GO:0043615 | astrocyte cell migration(GO:0043615) |
1.2 | 4.7 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
1.2 | 3.5 | GO:0005513 | detection of calcium ion(GO:0005513) |
1.2 | 2.3 | GO:0048664 | neuron fate determination(GO:0048664) |
1.2 | 1.2 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
1.2 | 3.5 | GO:0048696 | collateral sprouting in absence of injury(GO:0048669) regulation of collateral sprouting in absence of injury(GO:0048696) |
1.2 | 1.2 | GO:0061004 | pattern specification involved in kidney development(GO:0061004) renal system pattern specification(GO:0072048) |
1.2 | 1.2 | GO:2000275 | regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
1.2 | 5.8 | GO:0060539 | diaphragm development(GO:0060539) |
1.2 | 5.8 | GO:0009115 | xanthine catabolic process(GO:0009115) xanthine metabolic process(GO:0046110) |
1.1 | 3.4 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
1.1 | 3.4 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
1.1 | 5.7 | GO:0060179 | male mating behavior(GO:0060179) |
1.1 | 5.7 | GO:0021854 | hypothalamus development(GO:0021854) |
1.1 | 4.5 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
1.1 | 6.7 | GO:0071265 | amino acid salvage(GO:0043102) L-methionine biosynthetic process(GO:0071265) L-methionine salvage(GO:0071267) |
1.1 | 7.7 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
1.1 | 1.1 | GO:0048370 | lateral mesoderm morphogenesis(GO:0048369) lateral mesoderm formation(GO:0048370) lateral mesodermal cell differentiation(GO:0048371) |
1.1 | 3.3 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
1.1 | 1.1 | GO:0060751 | epithelial cell proliferation involved in mammary gland duct elongation(GO:0060750) branch elongation involved in mammary gland duct branching(GO:0060751) |
1.1 | 1.1 | GO:0003096 | renal sodium ion transport(GO:0003096) |
1.1 | 4.4 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
1.1 | 5.4 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
1.1 | 2.2 | GO:0044034 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
1.1 | 7.6 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
1.1 | 18.4 | GO:0007616 | long-term memory(GO:0007616) |
1.1 | 2.2 | GO:1903998 | regulation of eating behavior(GO:1903998) |
1.1 | 6.5 | GO:0060068 | vagina development(GO:0060068) |
1.1 | 3.2 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
1.1 | 75.3 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
1.1 | 3.2 | GO:0090148 | membrane fission(GO:0090148) |
1.1 | 31.1 | GO:0050885 | neuromuscular process controlling balance(GO:0050885) |
1.1 | 3.2 | GO:0035990 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
1.1 | 3.2 | GO:0010870 | positive regulation of receptor biosynthetic process(GO:0010870) |
1.1 | 1.1 | GO:0015705 | iodide transport(GO:0015705) |
1.1 | 1.1 | GO:2000463 | positive regulation of excitatory postsynaptic potential(GO:2000463) |
1.1 | 19.1 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
1.1 | 5.3 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
1.0 | 27.1 | GO:0007340 | acrosome reaction(GO:0007340) |
1.0 | 1.0 | GO:0030908 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
1.0 | 10.3 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
1.0 | 4.1 | GO:0014744 | positive regulation of muscle adaptation(GO:0014744) |
1.0 | 7.1 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
1.0 | 2.0 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
1.0 | 9.1 | GO:0098719 | sodium ion import(GO:0097369) sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
1.0 | 17.1 | GO:0007416 | synapse assembly(GO:0007416) |
1.0 | 3.0 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
1.0 | 11.0 | GO:0009404 | toxin metabolic process(GO:0009404) |
1.0 | 2.0 | GO:0003310 | pancreatic A cell differentiation(GO:0003310) |
1.0 | 4.0 | GO:0031034 | myosin filament assembly(GO:0031034) |
1.0 | 4.0 | GO:1903799 | negative regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903799) |
1.0 | 2.0 | GO:2000095 | regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000095) |
1.0 | 7.9 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
1.0 | 2.9 | GO:0007638 | mechanosensory behavior(GO:0007638) |
1.0 | 6.8 | GO:0006108 | malate metabolic process(GO:0006108) |
1.0 | 9.6 | GO:2001222 | regulation of neuron migration(GO:2001222) |
1.0 | 2.9 | GO:2001012 | mesenchymal cell differentiation involved in kidney development(GO:0072161) mesenchymal cell differentiation involved in renal system development(GO:2001012) |
1.0 | 2.9 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
1.0 | 1.0 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
0.9 | 2.8 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.9 | 0.9 | GO:2000018 | regulation of male gonad development(GO:2000018) |
0.9 | 4.7 | GO:1902774 | late endosome to lysosome transport(GO:1902774) |
0.9 | 6.5 | GO:0070986 | left/right axis specification(GO:0070986) |
0.9 | 2.8 | GO:0090158 | endoplasmic reticulum membrane organization(GO:0090158) |
0.9 | 13.0 | GO:0061049 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.9 | 0.9 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
0.9 | 1.8 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.9 | 3.7 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.9 | 3.6 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
0.9 | 2.7 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.9 | 5.4 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.9 | 8.1 | GO:0001967 | suckling behavior(GO:0001967) |
0.9 | 2.7 | GO:0031087 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.9 | 8.9 | GO:0060292 | long term synaptic depression(GO:0060292) |
0.9 | 8.0 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.9 | 4.4 | GO:0033762 | response to glucagon(GO:0033762) |
0.9 | 6.1 | GO:0015858 | nucleoside transport(GO:0015858) |
0.9 | 2.6 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
0.9 | 2.6 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
0.9 | 2.6 | GO:0060335 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
0.9 | 0.9 | GO:1901503 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) cellular lipid biosynthetic process(GO:0097384) ether biosynthetic process(GO:1901503) |
0.9 | 4.3 | GO:0051095 | regulation of helicase activity(GO:0051095) positive regulation of helicase activity(GO:0051096) |
0.9 | 1.7 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
0.9 | 1.7 | GO:0043045 | DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
0.9 | 5.1 | GO:0030638 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.9 | 3.4 | GO:0070365 | hepatocyte differentiation(GO:0070365) |
0.8 | 4.2 | GO:0072675 | osteoclast fusion(GO:0072675) |
0.8 | 2.5 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.8 | 2.5 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
0.8 | 6.7 | GO:0032509 | endosome transport via multivesicular body sorting pathway(GO:0032509) |
0.8 | 11.7 | GO:0019226 | transmission of nerve impulse(GO:0019226) |
0.8 | 0.8 | GO:0070672 | response to interleukin-15(GO:0070672) |
0.8 | 8.3 | GO:0036342 | post-anal tail morphogenesis(GO:0036342) |
0.8 | 3.3 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
0.8 | 2.4 | GO:0051001 | negative regulation of nitric-oxide synthase activity(GO:0051001) |
0.8 | 3.2 | GO:0035627 | ceramide transport(GO:0035627) |
0.8 | 1.6 | GO:0061047 | foregut regionalization(GO:0060423) lung field specification(GO:0060424) lung induction(GO:0060492) positive regulation of branching involved in lung morphogenesis(GO:0061047) |
0.8 | 1.6 | GO:0048294 | negative regulation of isotype switching to IgE isotypes(GO:0048294) |
0.8 | 4.8 | GO:0021936 | regulation of cerebellar granule cell precursor proliferation(GO:0021936) |
0.8 | 1.6 | GO:0046391 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.8 | 1.6 | GO:0014820 | tonic smooth muscle contraction(GO:0014820) |
0.8 | 6.4 | GO:0002084 | protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
0.8 | 14.4 | GO:0001573 | ganglioside metabolic process(GO:0001573) |
0.8 | 3.2 | GO:0003416 | endochondral bone growth(GO:0003416) |
0.8 | 0.8 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
0.8 | 2.3 | GO:0002906 | mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
0.8 | 2.3 | GO:0006166 | purine ribonucleoside salvage(GO:0006166) |
0.8 | 0.8 | GO:0021871 | forebrain regionalization(GO:0021871) |
0.8 | 0.8 | GO:0038171 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
0.8 | 2.3 | GO:0045897 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
0.8 | 0.8 | GO:0035995 | detection of muscle stretch(GO:0035995) |
0.8 | 5.3 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
0.8 | 3.8 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.7 | 17.2 | GO:0007632 | visual behavior(GO:0007632) |
0.7 | 2.2 | GO:0010166 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.7 | 0.7 | GO:0032346 | positive regulation of aldosterone metabolic process(GO:0032346) positive regulation of aldosterone biosynthetic process(GO:0032349) |
0.7 | 1.5 | GO:0061152 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.7 | 4.4 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
0.7 | 2.9 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.7 | 0.7 | GO:0043497 | regulation of protein heterodimerization activity(GO:0043497) |
0.7 | 6.5 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.7 | 3.6 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.7 | 2.2 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.7 | 0.7 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
0.7 | 2.9 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
0.7 | 1.4 | GO:0097112 | gamma-aminobutyric acid receptor clustering(GO:0097112) |
0.7 | 2.8 | GO:0035521 | monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
0.7 | 0.7 | GO:0060059 | embryonic retina morphogenesis in camera-type eye(GO:0060059) |
0.7 | 1.4 | GO:0035815 | positive regulation of renal sodium excretion(GO:0035815) |
0.7 | 5.5 | GO:0036093 | germ cell proliferation(GO:0036093) |
0.7 | 2.1 | GO:0045409 | negative regulation of interleukin-6 biosynthetic process(GO:0045409) |
0.7 | 5.5 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.7 | 3.4 | GO:0045349 | interferon-alpha biosynthetic process(GO:0045349) regulation of interferon-alpha biosynthetic process(GO:0045354) |
0.7 | 1.4 | GO:0046122 | purine deoxyribonucleoside metabolic process(GO:0046122) |
0.7 | 2.0 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
0.7 | 0.7 | GO:0048793 | pronephros development(GO:0048793) |
0.7 | 2.0 | GO:0001828 | inner cell mass cellular morphogenesis(GO:0001828) |
0.7 | 3.4 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.7 | 2.0 | GO:0042494 | detection of bacterial lipoprotein(GO:0042494) |
0.7 | 1.3 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.7 | 1.3 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
0.7 | 0.7 | GO:0001827 | inner cell mass cell fate commitment(GO:0001827) |
0.7 | 3.3 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
0.7 | 2.0 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
0.7 | 2.6 | GO:0019348 | dolichol metabolic process(GO:0019348) |
0.7 | 2.0 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
0.7 | 0.7 | GO:0032661 | regulation of interleukin-18 production(GO:0032661) |
0.6 | 1.3 | GO:0030222 | eosinophil differentiation(GO:0030222) |
0.6 | 2.6 | GO:0060923 | cardiac muscle cell fate commitment(GO:0060923) |
0.6 | 10.3 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.6 | 0.6 | GO:1904124 | microglial cell migration(GO:1904124) regulation of microglial cell migration(GO:1904139) |
0.6 | 3.2 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.6 | 3.8 | GO:0051503 | adenine nucleotide transport(GO:0051503) |
0.6 | 1.9 | GO:0019859 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
0.6 | 0.6 | GO:0002069 | columnar/cuboidal epithelial cell maturation(GO:0002069) |
0.6 | 5.7 | GO:0050962 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.6 | 1.9 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.6 | 1.3 | GO:0008292 | acetylcholine biosynthetic process(GO:0008292) acetate ester biosynthetic process(GO:1900620) |
0.6 | 1.8 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
0.6 | 4.8 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.6 | 4.8 | GO:0045217 | cell-cell junction maintenance(GO:0045217) |
0.6 | 1.8 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
0.6 | 5.4 | GO:0033523 | histone H2B ubiquitination(GO:0033523) |
0.6 | 1.2 | GO:1901857 | positive regulation of cellular respiration(GO:1901857) |
0.6 | 0.6 | GO:0001975 | response to amphetamine(GO:0001975) |
0.6 | 0.6 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
0.6 | 1.8 | GO:0002857 | positive regulation of natural killer cell mediated immune response to tumor cell(GO:0002857) positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002860) |
0.6 | 45.8 | GO:0097485 | neuron projection guidance(GO:0097485) |
0.6 | 5.2 | GO:0045056 | transcytosis(GO:0045056) |
0.6 | 0.6 | GO:0000189 | MAPK import into nucleus(GO:0000189) |
0.6 | 3.5 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.6 | 1.1 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
0.6 | 1.1 | GO:0051549 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
0.6 | 1.1 | GO:0033210 | leptin-mediated signaling pathway(GO:0033210) |
0.6 | 0.6 | GO:0034635 | glutathione transport(GO:0034635) tripeptide transport(GO:0042939) |
0.6 | 2.2 | GO:0033227 | dsRNA transport(GO:0033227) |
0.6 | 1.1 | GO:0065001 | specification of axis polarity(GO:0065001) |
0.6 | 2.2 | GO:0045410 | positive regulation of interleukin-6 biosynthetic process(GO:0045410) |
0.5 | 1.1 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
0.5 | 4.9 | GO:2000400 | positive regulation of T cell differentiation in thymus(GO:0033089) positive regulation of thymocyte aggregation(GO:2000400) |
0.5 | 3.3 | GO:0051418 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
0.5 | 3.8 | GO:0034626 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.5 | 1.1 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.5 | 8.9 | GO:0035249 | synaptic transmission, glutamatergic(GO:0035249) |
0.5 | 0.5 | GO:0009996 | negative regulation of cell fate specification(GO:0009996) |
0.5 | 2.1 | GO:0032049 | cardiolipin biosynthetic process(GO:0032049) |
0.5 | 1.0 | GO:0042891 | antibiotic transport(GO:0042891) |
0.5 | 0.5 | GO:0048752 | semicircular canal morphogenesis(GO:0048752) |
0.5 | 4.1 | GO:0016048 | detection of temperature stimulus(GO:0016048) |
0.5 | 3.1 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
0.5 | 3.1 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.5 | 1.5 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.5 | 4.6 | GO:0043651 | linoleic acid metabolic process(GO:0043651) |
0.5 | 4.6 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
0.5 | 0.5 | GO:0031443 | fast-twitch skeletal muscle fiber contraction(GO:0031443) |
0.5 | 2.0 | GO:2000035 | regulation of stem cell division(GO:2000035) |
0.5 | 1.5 | GO:0071542 | dopaminergic neuron differentiation(GO:0071542) |
0.5 | 2.5 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.5 | 3.9 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.5 | 0.5 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.5 | 1.0 | GO:0071670 | smooth muscle cell chemotaxis(GO:0071670) |
0.5 | 1.5 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
0.5 | 5.8 | GO:0095500 | acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
0.5 | 37.0 | GO:0007626 | locomotory behavior(GO:0007626) |
0.5 | 2.9 | GO:0010640 | regulation of platelet-derived growth factor receptor signaling pathway(GO:0010640) |
0.5 | 1.0 | GO:0070459 | prolactin secretion(GO:0070459) |
0.5 | 0.9 | GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
0.5 | 1.9 | GO:0006566 | threonine metabolic process(GO:0006566) |
0.5 | 0.5 | GO:2000321 | positive regulation of T-helper 17 cell differentiation(GO:2000321) |
0.5 | 3.7 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
0.5 | 10.3 | GO:0045494 | photoreceptor cell maintenance(GO:0045494) |
0.5 | 0.9 | GO:0051788 | response to misfolded protein(GO:0051788) |
0.5 | 0.5 | GO:1903116 | positive regulation of actin filament-based movement(GO:1903116) |
0.5 | 1.4 | GO:0015889 | cobalamin transport(GO:0015889) |
0.5 | 0.9 | GO:1904849 | positive regulation of cell chemotaxis to fibroblast growth factor(GO:1904849) positive regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000546) |
0.4 | 1.8 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.4 | 3.6 | GO:0048745 | smooth muscle tissue development(GO:0048745) |
0.4 | 3.6 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
0.4 | 6.6 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
0.4 | 0.4 | GO:1902805 | positive regulation of synaptic vesicle transport(GO:1902805) |
0.4 | 0.4 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
0.4 | 4.3 | GO:0043949 | regulation of cAMP-mediated signaling(GO:0043949) |
0.4 | 3.0 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.4 | 0.4 | GO:2000542 | negative regulation of gastrulation(GO:2000542) |
0.4 | 6.9 | GO:0030488 | tRNA methylation(GO:0030488) |
0.4 | 17.2 | GO:0002028 | regulation of sodium ion transport(GO:0002028) |
0.4 | 0.4 | GO:0070885 | negative regulation of calcineurin-NFAT signaling cascade(GO:0070885) |
0.4 | 1.7 | GO:0099601 | regulation of neurotransmitter receptor activity(GO:0099601) |
0.4 | 0.4 | GO:1903975 | regulation of glial cell migration(GO:1903975) |
0.4 | 1.6 | GO:0015813 | L-glutamate transport(GO:0015813) |
0.4 | 0.8 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
0.4 | 0.8 | GO:0035989 | tendon development(GO:0035989) |
0.4 | 2.5 | GO:0030828 | positive regulation of cGMP biosynthetic process(GO:0030828) |
0.4 | 3.7 | GO:0006266 | DNA ligation(GO:0006266) |
0.4 | 0.4 | GO:0072061 | inner medullary collecting duct development(GO:0072061) |
0.4 | 5.3 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
0.4 | 2.0 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
0.4 | 6.0 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.4 | 0.8 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
0.4 | 2.8 | GO:1902260 | negative regulation of delayed rectifier potassium channel activity(GO:1902260) negative regulation of voltage-gated potassium channel activity(GO:1903817) |
0.4 | 0.4 | GO:0050705 | regulation of interleukin-1 alpha secretion(GO:0050705) |
0.4 | 2.4 | GO:0043649 | dicarboxylic acid catabolic process(GO:0043649) |
0.4 | 2.0 | GO:0051451 | myoblast migration(GO:0051451) |
0.4 | 1.2 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.4 | 6.6 | GO:0046928 | regulation of neurotransmitter secretion(GO:0046928) |
0.4 | 1.9 | GO:0016082 | synaptic vesicle priming(GO:0016082) |
0.4 | 8.8 | GO:0021987 | cerebral cortex development(GO:0021987) |
0.4 | 0.4 | GO:0002282 | microglial cell activation involved in immune response(GO:0002282) |
0.4 | 0.8 | GO:0071374 | cellular response to parathyroid hormone stimulus(GO:0071374) |
0.4 | 2.3 | GO:0042474 | middle ear morphogenesis(GO:0042474) |
0.4 | 1.1 | GO:0036376 | sodium ion export from cell(GO:0036376) |
0.4 | 0.4 | GO:0060460 | left lung development(GO:0060459) left lung morphogenesis(GO:0060460) |
0.4 | 2.2 | GO:0043416 | regulation of skeletal muscle tissue regeneration(GO:0043416) |
0.4 | 1.5 | GO:0046602 | regulation of mitotic centrosome separation(GO:0046602) |
0.4 | 0.7 | GO:1901069 | guanosine-containing compound catabolic process(GO:1901069) |
0.4 | 1.5 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.4 | 1.5 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.4 | 0.7 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
0.4 | 1.5 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.4 | 2.2 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.4 | 1.8 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.4 | 0.4 | GO:0014738 | regulation of muscle hyperplasia(GO:0014738) muscle hyperplasia(GO:0014900) |
0.4 | 0.4 | GO:0038033 | positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) |
0.3 | 1.0 | GO:0032066 | nucleolus to nucleoplasm transport(GO:0032066) |
0.3 | 1.0 | GO:0050654 | chondroitin sulfate proteoglycan metabolic process(GO:0050654) |
0.3 | 1.0 | GO:0033026 | negative regulation of mast cell apoptotic process(GO:0033026) |
0.3 | 0.7 | GO:0048550 | negative regulation of pinocytosis(GO:0048550) |
0.3 | 1.4 | GO:0060732 | positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
0.3 | 0.3 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
0.3 | 1.4 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
0.3 | 0.7 | GO:0010578 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
0.3 | 7.4 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
0.3 | 0.3 | GO:0010986 | positive regulation of lipoprotein particle clearance(GO:0010986) |
0.3 | 0.3 | GO:0036257 | multivesicular body organization(GO:0036257) |
0.3 | 0.3 | GO:0072198 | mesenchymal cell proliferation involved in ureter development(GO:0072198) regulation of mesenchymal cell proliferation involved in ureter development(GO:0072199) |
0.3 | 0.3 | GO:0072205 | metanephric collecting duct development(GO:0072205) |
0.3 | 4.0 | GO:0007019 | microtubule depolymerization(GO:0007019) |
0.3 | 0.3 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.3 | 2.6 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
0.3 | 0.3 | GO:0036006 | response to macrophage colony-stimulating factor(GO:0036005) cellular response to macrophage colony-stimulating factor stimulus(GO:0036006) |
0.3 | 2.3 | GO:0010842 | retina layer formation(GO:0010842) |
0.3 | 2.6 | GO:0032835 | glomerulus development(GO:0032835) |
0.3 | 1.3 | GO:1903333 | negative regulation of protein folding(GO:1903333) |
0.3 | 1.0 | GO:0046499 | S-adenosylmethioninamine metabolic process(GO:0046499) |
0.3 | 0.7 | GO:0002606 | positive regulation of dendritic cell antigen processing and presentation(GO:0002606) |
0.3 | 0.6 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.3 | 1.6 | GO:0090308 | regulation of methylation-dependent chromatin silencing(GO:0090308) |
0.3 | 0.6 | GO:0035810 | positive regulation of urine volume(GO:0035810) |
0.3 | 0.6 | GO:0042048 | olfactory behavior(GO:0042048) |
0.3 | 9.9 | GO:0099643 | neurotransmitter secretion(GO:0007269) signal release from synapse(GO:0099643) |
0.3 | 1.9 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
0.3 | 0.6 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
0.3 | 0.9 | GO:0046379 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
0.3 | 0.6 | GO:0097070 | ductus arteriosus closure(GO:0097070) |
0.3 | 0.9 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
0.3 | 5.9 | GO:0043392 | negative regulation of DNA binding(GO:0043392) |
0.3 | 2.8 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.3 | 1.5 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
0.3 | 0.6 | GO:0046880 | regulation of follicle-stimulating hormone secretion(GO:0046880) |
0.3 | 0.9 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.3 | 0.9 | GO:0061370 | testosterone biosynthetic process(GO:0061370) |
0.3 | 6.2 | GO:0034605 | cellular response to heat(GO:0034605) |
0.3 | 0.3 | GO:1901509 | regulation of endothelial tube morphogenesis(GO:1901509) |
0.3 | 0.6 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.3 | 0.6 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
0.3 | 0.9 | GO:0072498 | embryonic skeletal joint development(GO:0072498) |
0.3 | 0.3 | GO:0070428 | regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070428) |
0.3 | 0.8 | GO:0008306 | associative learning(GO:0008306) |
0.3 | 0.6 | GO:0070427 | nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
0.3 | 0.8 | GO:0048263 | determination of dorsal/ventral asymmetry(GO:0048262) determination of dorsal identity(GO:0048263) |
0.3 | 2.2 | GO:0071380 | cellular response to prostaglandin E stimulus(GO:0071380) |
0.3 | 4.4 | GO:0010107 | potassium ion import(GO:0010107) |
0.3 | 1.1 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.3 | 0.3 | GO:2000857 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
0.3 | 0.5 | GO:0048853 | forebrain morphogenesis(GO:0048853) |
0.3 | 1.6 | GO:0006983 | ER overload response(GO:0006983) |
0.3 | 2.9 | GO:0043268 | positive regulation of potassium ion transport(GO:0043268) |
0.3 | 0.5 | GO:0060012 | synaptic transmission, glycinergic(GO:0060012) |
0.3 | 1.3 | GO:0071569 | protein ufmylation(GO:0071569) |
0.3 | 0.8 | GO:0014912 | negative regulation of smooth muscle cell migration(GO:0014912) |
0.3 | 0.3 | GO:0046884 | follicle-stimulating hormone secretion(GO:0046884) |
0.3 | 1.3 | GO:0071397 | cellular response to cholesterol(GO:0071397) |
0.3 | 0.8 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
0.3 | 0.8 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
0.3 | 0.5 | GO:0042940 | D-amino acid transport(GO:0042940) |
0.3 | 0.8 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
0.3 | 1.0 | GO:0008347 | glial cell migration(GO:0008347) |
0.2 | 0.2 | GO:0048859 | formation of anatomical boundary(GO:0048859) |
0.2 | 0.2 | GO:0060157 | urinary bladder development(GO:0060157) |
0.2 | 5.9 | GO:0090662 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
0.2 | 2.5 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
0.2 | 0.5 | GO:0035697 | CD8-positive, alpha-beta T cell extravasation(GO:0035697) regulation of CD8-positive, alpha-beta T cell extravasation(GO:2000449) |
0.2 | 0.5 | GO:0008089 | anterograde axonal transport(GO:0008089) |
0.2 | 0.5 | GO:1990034 | calcium ion export from cell(GO:1990034) |
0.2 | 1.7 | GO:0045076 | regulation of interleukin-2 biosynthetic process(GO:0045076) |
0.2 | 0.2 | GO:0070460 | thyroid-stimulating hormone secretion(GO:0070460) |
0.2 | 0.2 | GO:2000680 | rubidium ion transport(GO:0035826) regulation of rubidium ion transport(GO:2000680) |
0.2 | 1.2 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
0.2 | 0.5 | GO:0010446 | response to alkaline pH(GO:0010446) |
0.2 | 0.9 | GO:0042220 | response to cocaine(GO:0042220) |
0.2 | 0.7 | GO:0016068 | regulation of type I hypersensitivity(GO:0001810) positive regulation of type I hypersensitivity(GO:0001812) type I hypersensitivity(GO:0016068) |
0.2 | 0.4 | GO:0034239 | regulation of macrophage fusion(GO:0034239) |
0.2 | 0.4 | GO:0006382 | adenosine to inosine editing(GO:0006382) |
0.2 | 1.0 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.2 | 0.6 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.2 | 0.2 | GO:1903587 | regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903587) |
0.2 | 1.6 | GO:1990173 | protein localization to nuclear body(GO:1903405) protein localization to Cajal body(GO:1904867) regulation of protein localization to Cajal body(GO:1904869) positive regulation of protein localization to Cajal body(GO:1904871) protein localization to nucleoplasm(GO:1990173) |
0.2 | 1.0 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.2 | 0.2 | GO:0032276 | regulation of gonadotropin secretion(GO:0032276) |
0.2 | 0.2 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
0.2 | 0.4 | GO:0070268 | cornification(GO:0070268) |
0.2 | 0.2 | GO:0061043 | regulation of vascular wound healing(GO:0061043) |
0.2 | 0.6 | GO:0044065 | regulation of respiratory system process(GO:0044065) |
0.2 | 2.3 | GO:0000281 | mitotic cytokinesis(GO:0000281) |
0.2 | 0.4 | GO:0045113 | regulation of integrin biosynthetic process(GO:0045113) |
0.2 | 1.0 | GO:0072540 | T-helper 17 cell lineage commitment(GO:0072540) |
0.2 | 0.6 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.2 | 1.1 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.2 | 0.5 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.2 | 2.9 | GO:0048642 | negative regulation of skeletal muscle tissue development(GO:0048642) |
0.2 | 0.5 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
0.2 | 0.2 | GO:2000474 | regulation of opioid receptor signaling pathway(GO:2000474) |
0.2 | 0.5 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.2 | 0.3 | GO:2000553 | positive regulation of T-helper 2 cell cytokine production(GO:2000553) |
0.2 | 3.9 | GO:0072384 | organelle transport along microtubule(GO:0072384) |
0.2 | 0.8 | GO:0071800 | podosome assembly(GO:0071800) |
0.2 | 0.3 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.2 | 0.6 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
0.2 | 3.9 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
0.2 | 0.5 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.2 | 0.2 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
0.2 | 0.3 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.2 | 0.3 | GO:0048254 | snoRNA localization(GO:0048254) |
0.1 | 0.6 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.1 | 0.1 | GO:1902947 | regulation of tau-protein kinase activity(GO:1902947) |
0.1 | 0.3 | GO:1901252 | regulation of intracellular transport of viral material(GO:1901252) |
0.1 | 0.3 | GO:0071798 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.1 | 0.6 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.1 | 0.1 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
0.1 | 1.8 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.1 | 0.5 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.1 | 0.1 | GO:1903208 | neuron death in response to hydrogen peroxide(GO:0036476) regulation of hydrogen peroxide-induced neuron death(GO:1903207) negative regulation of hydrogen peroxide-induced neuron death(GO:1903208) |
0.1 | 1.7 | GO:0048240 | sperm capacitation(GO:0048240) |
0.1 | 0.4 | GO:0070601 | centromeric sister chromatid cohesion(GO:0070601) |
0.1 | 0.2 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.1 | 0.4 | GO:0060988 | lipid tube assembly(GO:0060988) |
0.1 | 0.3 | GO:0019086 | late viral transcription(GO:0019086) |
0.1 | 0.8 | GO:0042346 | positive regulation of NF-kappaB import into nucleus(GO:0042346) |
0.1 | 0.3 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
0.1 | 0.2 | GO:2000599 | regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
0.1 | 1.2 | GO:0097352 | autophagosome maturation(GO:0097352) |
0.1 | 4.7 | GO:0001578 | microtubule bundle formation(GO:0001578) |
0.1 | 0.1 | GO:0035934 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
0.1 | 0.2 | GO:0071242 | cellular response to ammonium ion(GO:0071242) |
0.1 | 3.5 | GO:0030705 | cytoskeleton-dependent intracellular transport(GO:0030705) |
0.1 | 0.3 | GO:0044838 | cell quiescence(GO:0044838) |
0.1 | 0.1 | GO:1990168 | protein K29-linked deubiquitination(GO:0035523) protein K33-linked deubiquitination(GO:1990168) |
0.1 | 0.3 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.1 | 1.2 | GO:0050435 | beta-amyloid metabolic process(GO:0050435) |
0.1 | 1.1 | GO:0006515 | misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
0.1 | 0.3 | GO:0070423 | nucleotide-binding oligomerization domain containing signaling pathway(GO:0070423) nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070431) |
0.1 | 0.1 | GO:2000010 | positive regulation of protein localization to cell surface(GO:2000010) |
0.1 | 0.1 | GO:0086066 | atrial cardiac muscle cell action potential(GO:0086014) atrial cardiac muscle cell to AV node cell signaling(GO:0086026) atrial cardiac muscle cell to AV node cell communication(GO:0086066) |
0.1 | 0.3 | GO:0046015 | regulation of transcription by glucose(GO:0046015) |
0.1 | 0.1 | GO:0002930 | trabecular meshwork development(GO:0002930) ciliary body morphogenesis(GO:0061073) |
0.1 | 0.2 | GO:0032687 | negative regulation of interferon-alpha production(GO:0032687) |
0.1 | 0.2 | GO:0015820 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.1 | 0.1 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
0.1 | 0.6 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) |
0.1 | 0.2 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.1 | 0.1 | GO:0045091 | regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045091) negative regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045869) |
0.1 | 0.1 | GO:0043587 | tongue morphogenesis(GO:0043587) |
0.1 | 0.1 | GO:0003214 | cardiac left ventricle morphogenesis(GO:0003214) |
0.1 | 0.4 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.1 | 0.1 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
0.1 | 0.1 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
0.1 | 0.1 | GO:2001201 | transforming growth factor-beta secretion(GO:0038044) regulation of transforming growth factor-beta secretion(GO:2001201) |
0.1 | 0.6 | GO:0006744 | ubiquinone biosynthetic process(GO:0006744) |
0.1 | 0.1 | GO:0051025 | negative regulation of immunoglobulin secretion(GO:0051025) |
0.1 | 0.4 | GO:0006828 | manganese ion transport(GO:0006828) |
0.1 | 0.8 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
0.1 | 0.1 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.1 | 0.1 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
0.1 | 1.2 | GO:0006400 | tRNA modification(GO:0006400) |
0.1 | 0.8 | GO:0031122 | cytoplasmic microtubule organization(GO:0031122) |
0.1 | 0.1 | GO:0060618 | nipple development(GO:0060618) |
0.0 | 1.1 | GO:1902476 | chloride transmembrane transport(GO:1902476) |
0.0 | 0.1 | GO:0001923 | B-1 B cell differentiation(GO:0001923) |
0.0 | 0.1 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
0.0 | 0.1 | GO:1901874 | regulation of post-translational protein modification(GO:1901873) negative regulation of post-translational protein modification(GO:1901874) |
0.0 | 0.0 | GO:0038001 | paracrine signaling(GO:0038001) |
0.0 | 0.3 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.0 | 0.0 | GO:0015824 | proline transport(GO:0015824) |
0.0 | 0.0 | GO:0060729 | intestinal epithelial structure maintenance(GO:0060729) |
0.0 | 0.0 | GO:0061055 | myotome development(GO:0061055) |
0.0 | 0.1 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.0 | 0.5 | GO:0048168 | regulation of neuronal synaptic plasticity(GO:0048168) |
0.0 | 0.1 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.0 | 0.1 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.0 | 0.1 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.0 | 0.2 | GO:0051127 | positive regulation of actin nucleation(GO:0051127) |
0.0 | 0.1 | GO:0030311 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.0 | 0.0 | GO:0045324 | late endosome to vacuole transport(GO:0045324) |
0.0 | 0.1 | GO:0033578 | protein glycosylation in Golgi(GO:0033578) |
0.0 | 0.0 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
0.0 | 2.4 | GO:0019236 | response to pheromone(GO:0019236) |
0.0 | 0.1 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
0.0 | 0.0 | GO:0097012 | response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
0.0 | 0.0 | GO:0015865 | purine nucleotide transport(GO:0015865) |
0.0 | 0.0 | GO:1904749 | regulation of protein localization to nucleolus(GO:1904749) positive regulation of protein localization to nucleolus(GO:1904751) |
0.0 | 0.1 | GO:2000774 | positive regulation of cellular senescence(GO:2000774) |
0.0 | 0.1 | GO:1990403 | embryonic brain development(GO:1990403) |
0.0 | 0.0 | GO:0007635 | chemosensory behavior(GO:0007635) |
0.0 | 0.3 | GO:0051310 | metaphase plate congression(GO:0051310) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
8.5 | 94.0 | GO:0043194 | axon initial segment(GO:0043194) |
8.4 | 58.6 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
7.8 | 46.8 | GO:0031258 | lamellipodium membrane(GO:0031258) |
6.6 | 19.8 | GO:0072534 | perineuronal net(GO:0072534) |
5.8 | 29.2 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
5.7 | 51.4 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
4.9 | 49.2 | GO:0035253 | ciliary rootlet(GO:0035253) |
4.5 | 13.6 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
4.3 | 12.9 | GO:0097451 | glial limiting end-foot(GO:0097451) |
4.3 | 25.5 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
4.0 | 28.0 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
3.9 | 27.2 | GO:0030285 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
3.6 | 14.4 | GO:0044308 | axonal spine(GO:0044308) |
3.5 | 13.9 | GO:0030868 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
3.4 | 10.1 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
3.3 | 9.9 | GO:0033010 | paranodal junction(GO:0033010) |
3.2 | 3.2 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
3.2 | 9.5 | GO:0097433 | dense body(GO:0097433) |
3.1 | 9.4 | GO:0097427 | microtubule bundle(GO:0097427) |
3.1 | 12.5 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
3.0 | 53.8 | GO:0060077 | inhibitory synapse(GO:0060077) |
3.0 | 11.9 | GO:0008091 | spectrin(GO:0008091) |
2.8 | 5.5 | GO:0044316 | cone cell pedicle(GO:0044316) |
2.8 | 22.0 | GO:0042788 | polysomal ribosome(GO:0042788) |
2.8 | 27.5 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
2.7 | 59.5 | GO:0048786 | presynaptic active zone(GO:0048786) |
2.7 | 10.7 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
2.6 | 7.7 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
2.5 | 10.2 | GO:0035748 | myelin sheath abaxonal region(GO:0035748) |
2.5 | 24.8 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
2.5 | 19.8 | GO:0071437 | invadopodium(GO:0071437) |
2.5 | 22.3 | GO:0031527 | filopodium membrane(GO:0031527) |
2.4 | 9.6 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
2.4 | 9.6 | GO:0044326 | dendritic spine neck(GO:0044326) |
2.4 | 14.1 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
2.3 | 14.1 | GO:0032584 | growth cone membrane(GO:0032584) |
2.3 | 58.2 | GO:0044295 | axonal growth cone(GO:0044295) |
2.3 | 15.9 | GO:0043083 | synaptic cleft(GO:0043083) |
2.2 | 6.7 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
2.2 | 50.7 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
2.2 | 6.5 | GO:0005608 | laminin-3 complex(GO:0005608) |
2.1 | 6.4 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
2.1 | 2.1 | GO:0035838 | growing cell tip(GO:0035838) |
2.1 | 4.2 | GO:0097441 | basilar dendrite(GO:0097441) |
2.1 | 20.6 | GO:0032433 | filopodium tip(GO:0032433) |
2.0 | 55.2 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
2.0 | 28.3 | GO:0030673 | axolemma(GO:0030673) |
2.0 | 200.3 | GO:0030426 | growth cone(GO:0030426) |
1.8 | 16.6 | GO:0000813 | ESCRT I complex(GO:0000813) |
1.8 | 9.1 | GO:0071547 | piP-body(GO:0071547) |
1.8 | 16.4 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
1.8 | 25.3 | GO:0043205 | fibril(GO:0043205) |
1.7 | 1.7 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
1.7 | 46.2 | GO:0042734 | presynaptic membrane(GO:0042734) |
1.7 | 5.1 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
1.7 | 10.2 | GO:0005859 | muscle myosin complex(GO:0005859) |
1.7 | 18.2 | GO:0030061 | mitochondrial crista(GO:0030061) |
1.6 | 13.1 | GO:0001520 | outer dense fiber(GO:0001520) |
1.6 | 3.1 | GO:0070765 | gamma-secretase complex(GO:0070765) |
1.6 | 6.3 | GO:0030314 | junctional membrane complex(GO:0030314) |
1.5 | 21.4 | GO:1902711 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
1.5 | 44.7 | GO:0031594 | neuromuscular junction(GO:0031594) |
1.5 | 7.3 | GO:0005579 | membrane attack complex(GO:0005579) |
1.4 | 9.9 | GO:0060076 | excitatory synapse(GO:0060076) |
1.4 | 2.8 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
1.4 | 4.2 | GO:0048179 | activin receptor complex(GO:0048179) |
1.4 | 6.9 | GO:0045098 | type III intermediate filament(GO:0045098) |
1.4 | 4.1 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
1.3 | 1.3 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
1.3 | 5.3 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
1.3 | 14.4 | GO:0034704 | calcium channel complex(GO:0034704) |
1.3 | 19.5 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
1.3 | 160.1 | GO:0099572 | postsynaptic density(GO:0014069) postsynaptic specialization(GO:0099572) |
1.2 | 3.7 | GO:0042585 | germinal vesicle(GO:0042585) |
1.2 | 3.6 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
1.2 | 7.2 | GO:0016012 | sarcoglycan complex(GO:0016012) |
1.2 | 12.8 | GO:0042555 | MCM complex(GO:0042555) |
1.2 | 116.6 | GO:0045211 | postsynaptic membrane(GO:0045211) |
1.2 | 8.1 | GO:0034518 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
1.2 | 11.6 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
1.1 | 3.4 | GO:0001674 | female germ cell nucleus(GO:0001674) |
1.1 | 3.4 | GO:0070552 | BRISC complex(GO:0070552) |
1.1 | 4.4 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
1.1 | 4.4 | GO:0043202 | lysosomal lumen(GO:0043202) |
1.0 | 3.1 | GO:0035061 | interchromatin granule(GO:0035061) |
1.0 | 16.6 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
1.0 | 3.1 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
1.0 | 4.0 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
1.0 | 3.0 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
1.0 | 6.8 | GO:0033263 | CORVET complex(GO:0033263) |
1.0 | 4.8 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
1.0 | 4.8 | GO:0016589 | NURF complex(GO:0016589) |
0.9 | 5.4 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.9 | 8.1 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.9 | 15.7 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.9 | 3.4 | GO:0000931 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
0.8 | 14.4 | GO:0005614 | interstitial matrix(GO:0005614) |
0.8 | 38.8 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.8 | 2.4 | GO:0000802 | transverse filament(GO:0000802) |
0.8 | 52.7 | GO:0008021 | synaptic vesicle(GO:0008021) |
0.8 | 3.2 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.8 | 5.5 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.7 | 19.4 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.7 | 5.8 | GO:0060091 | kinocilium(GO:0060091) |
0.7 | 1.4 | GO:1990635 | proximal dendrite(GO:1990635) |
0.7 | 2.1 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.7 | 5.6 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.7 | 2.0 | GO:0005784 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.7 | 2.7 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.7 | 7.9 | GO:0042575 | DNA polymerase complex(GO:0042575) |
0.7 | 2.0 | GO:0005879 | axonemal microtubule(GO:0005879) |
0.6 | 2.6 | GO:0097422 | tubular endosome(GO:0097422) |
0.6 | 19.2 | GO:0005921 | gap junction(GO:0005921) |
0.6 | 4.5 | GO:0097440 | apical dendrite(GO:0097440) |
0.6 | 20.7 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.6 | 1.9 | GO:0071797 | LUBAC complex(GO:0071797) |
0.6 | 0.6 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.6 | 1.8 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.6 | 8.4 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.6 | 5.3 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.6 | 8.8 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.6 | 1.2 | GO:1990357 | terminal web(GO:1990357) |
0.6 | 2.3 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.6 | 1.7 | GO:0033162 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.6 | 1.7 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.6 | 4.0 | GO:0097542 | ciliary tip(GO:0097542) |
0.6 | 4.0 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.6 | 2.8 | GO:0090665 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.6 | 1.1 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.5 | 6.3 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.5 | 117.4 | GO:0030425 | dendrite(GO:0030425) |
0.5 | 1.0 | GO:0036195 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.5 | 2.0 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.5 | 1.0 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
0.5 | 5.4 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.5 | 1.9 | GO:0061574 | ASAP complex(GO:0061574) |
0.4 | 4.9 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.4 | 1.3 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.4 | 1.8 | GO:0070545 | PeBoW complex(GO:0070545) |
0.4 | 2.2 | GO:0061617 | MICOS complex(GO:0061617) |
0.4 | 1.3 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.4 | 2.6 | GO:0070847 | core mediator complex(GO:0070847) |
0.4 | 1.7 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
0.4 | 3.4 | GO:0032797 | SMN complex(GO:0032797) |
0.4 | 1.5 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.4 | 1.5 | GO:0030897 | HOPS complex(GO:0030897) |
0.4 | 0.7 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.4 | 11.7 | GO:0043204 | perikaryon(GO:0043204) |
0.4 | 8.0 | GO:0034451 | centriolar satellite(GO:0034451) |
0.4 | 4.7 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.3 | 3.0 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.3 | 30.9 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.3 | 1.5 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
0.3 | 1.5 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.3 | 1.1 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.3 | 1.3 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.3 | 1.9 | GO:0030677 | nucleolar ribonuclease P complex(GO:0005655) ribonuclease P complex(GO:0030677) multimeric ribonuclease P complex(GO:0030681) |
0.3 | 0.3 | GO:0032279 | asymmetric synapse(GO:0032279) |
0.3 | 0.8 | GO:0071942 | XPC complex(GO:0071942) |
0.3 | 0.5 | GO:0043511 | inhibin complex(GO:0043511) |
0.2 | 0.6 | GO:0036396 | MIS complex(GO:0036396) |
0.2 | 1.1 | GO:0032300 | mismatch repair complex(GO:0032300) |
0.2 | 1.7 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.2 | 1.6 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.2 | 4.6 | GO:0000314 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.2 | 0.8 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.1 | 4.4 | GO:0005581 | collagen trimer(GO:0005581) |
0.1 | 0.7 | GO:0097255 | R2TP complex(GO:0097255) |
0.1 | 0.3 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.1 | 0.6 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
0.1 | 1.2 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.1 | 0.5 | GO:0034448 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.1 | 0.4 | GO:0072687 | meiotic spindle(GO:0072687) |
0.1 | 0.4 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.1 | 0.6 | GO:0000778 | condensed nuclear chromosome kinetochore(GO:0000778) |
0.1 | 0.4 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.1 | 0.5 | GO:0005796 | Golgi lumen(GO:0005796) |
0.1 | 0.7 | GO:0036157 | outer dynein arm(GO:0036157) |
0.1 | 0.2 | GO:0032010 | phagolysosome(GO:0032010) |
0.1 | 1.0 | GO:0001673 | male germ cell nucleus(GO:0001673) |
0.1 | 0.2 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.1 | 3.5 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.1 | 4.2 | GO:0055037 | recycling endosome(GO:0055037) |
0.1 | 1.0 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.0 | 0.4 | GO:0000124 | SAGA complex(GO:0000124) |
0.0 | 0.2 | GO:0034991 | nuclear meiotic cohesin complex(GO:0034991) |
0.0 | 0.2 | GO:0033270 | paranode region of axon(GO:0033270) |
0.0 | 0.2 | GO:0070187 | telosome(GO:0070187) |
0.0 | 0.3 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.0 | 0.7 | GO:0032154 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.0 | 0.1 | GO:0071014 | post-mRNA release spliceosomal complex(GO:0071014) |
0.0 | 0.2 | GO:0045263 | proton-transporting ATP synthase complex, coupling factor F(o)(GO:0045263) |
0.0 | 1.5 | GO:0030027 | lamellipodium(GO:0030027) |
0.0 | 0.1 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.0 | 2.7 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
28.4 | 85.2 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
10.2 | 30.7 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
9.5 | 28.5 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
9.3 | 46.6 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
9.2 | 37.0 | GO:0032051 | clathrin light chain binding(GO:0032051) |
8.8 | 44.2 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
7.9 | 23.6 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
7.6 | 38.1 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
7.6 | 22.7 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
7.4 | 22.2 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
7.2 | 28.9 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
7.2 | 28.7 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
6.1 | 30.6 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
5.7 | 17.2 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
5.5 | 16.5 | GO:0016909 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
5.4 | 10.8 | GO:0045503 | dynein light chain binding(GO:0045503) |
5.3 | 15.9 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
5.1 | 25.4 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
5.0 | 29.8 | GO:0004385 | guanylate kinase activity(GO:0004385) |
4.9 | 9.8 | GO:0005167 | neurotrophin TRK receptor binding(GO:0005167) |
4.6 | 50.1 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
4.5 | 13.4 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
4.4 | 13.3 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
4.4 | 17.6 | GO:0004065 | arylsulfatase activity(GO:0004065) |
4.3 | 30.3 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
4.1 | 16.6 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
4.1 | 12.2 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
4.0 | 47.5 | GO:0005313 | L-glutamate transmembrane transporter activity(GO:0005313) acidic amino acid transmembrane transporter activity(GO:0015172) |
3.9 | 23.7 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
3.9 | 11.8 | GO:0070699 | type II activin receptor binding(GO:0070699) |
3.8 | 11.5 | GO:0017002 | activin-activated receptor activity(GO:0017002) |
3.7 | 14.8 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
3.6 | 17.8 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
3.5 | 10.4 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
3.4 | 30.2 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
3.4 | 6.7 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
3.2 | 15.8 | GO:0042609 | CD4 receptor binding(GO:0042609) |
3.1 | 12.6 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
3.1 | 12.5 | GO:0038064 | collagen receptor activity(GO:0038064) |
3.1 | 9.3 | GO:0005148 | prolactin receptor binding(GO:0005148) |
3.1 | 12.4 | GO:0034056 | estrogen response element binding(GO:0034056) |
3.1 | 42.9 | GO:0045295 | gamma-catenin binding(GO:0045295) |
3.1 | 18.4 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
3.1 | 33.6 | GO:0005522 | profilin binding(GO:0005522) |
3.0 | 21.3 | GO:0003680 | AT DNA binding(GO:0003680) |
3.0 | 12.1 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
3.0 | 21.1 | GO:0019992 | diacylglycerol binding(GO:0019992) |
3.0 | 69.0 | GO:0045499 | chemorepellent activity(GO:0045499) |
3.0 | 8.9 | GO:0035939 | microsatellite binding(GO:0035939) |
2.9 | 23.4 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
2.8 | 11.3 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
2.7 | 8.2 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
2.7 | 8.0 | GO:0018592 | mono-butyltin dioxygenase activity(GO:0018586) tri-n-butyltin dioxygenase activity(GO:0018588) di-n-butyltin dioxygenase activity(GO:0018589) methylsilanetriol hydroxylase activity(GO:0018590) methyl tertiary butyl ether 3-monooxygenase activity(GO:0018591) 4-nitrocatechol 4-monooxygenase activity(GO:0018592) 4-chlorophenoxyacetate monooxygenase activity(GO:0018593) tert-butanol 2-monooxygenase activity(GO:0018594) alpha-pinene monooxygenase activity(GO:0018595) dimethylsilanediol hydroxylase activity(GO:0018596) ammonia monooxygenase activity(GO:0018597) hydroxymethylsilanetriol oxidase activity(GO:0018598) 2-hydroxyisobutyrate 3-monooxygenase activity(GO:0018599) alpha-pinene dehydrogenase activity(GO:0018600) bisphenol A hydroxylase B activity(GO:0034559) 2,2-bis(4-hydroxyphenyl)-1-propanol hydroxylase activity(GO:0034562) 9-fluorenone-3,4-dioxygenase activity(GO:0034786) anthracene 9,10-dioxygenase activity(GO:0034816) 2-(methylthio)benzothiazole monooxygenase activity(GO:0034857) 2-hydroxybenzothiazole monooxygenase activity(GO:0034858) benzothiazole monooxygenase activity(GO:0034859) 2,6-dihydroxybenzothiazole monooxygenase activity(GO:0034862) pinacolone 5-monooxygenase activity(GO:0034870) thioacetamide S-oxygenase activity(GO:0034873) thioacetamide S-oxide S-oxygenase activity(GO:0034874) endosulfan monooxygenase I activity(GO:0034888) N-nitrodimethylamine hydroxylase activity(GO:0034893) 4-(1-ethyl-1,4-dimethyl-pentyl)phenol monoxygenase activity(GO:0034897) endosulfan ether monooxygenase activity(GO:0034903) pyrene 4,5-monooxygenase activity(GO:0034925) pyrene 1,2-monooxygenase activity(GO:0034927) 1-hydroxypyrene 6,7-monooxygenase activity(GO:0034928) 1-hydroxypyrene 7,8-monooxygenase activity(GO:0034929) phenylboronic acid monooxygenase activity(GO:0034950) spheroidene monooxygenase activity(GO:0043823) |
2.7 | 39.9 | GO:0016805 | dipeptidase activity(GO:0016805) |
2.7 | 13.3 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
2.7 | 8.0 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
2.6 | 10.3 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
2.6 | 25.7 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
2.5 | 5.0 | GO:0051425 | PTB domain binding(GO:0051425) |
2.5 | 22.5 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
2.4 | 12.1 | GO:0048495 | Roundabout binding(GO:0048495) |
2.4 | 31.4 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
2.4 | 9.6 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
2.4 | 7.1 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
2.4 | 30.9 | GO:0031005 | filamin binding(GO:0031005) |
2.4 | 4.7 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
2.3 | 25.7 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
2.3 | 2.3 | GO:0038191 | neuropilin binding(GO:0038191) |
2.3 | 13.7 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
2.2 | 66.7 | GO:0017147 | Wnt-protein binding(GO:0017147) |
2.2 | 8.8 | GO:0097001 | ceramide binding(GO:0097001) |
2.2 | 8.7 | GO:0004985 | opioid receptor activity(GO:0004985) |
2.1 | 6.4 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
2.1 | 8.4 | GO:0071253 | connexin binding(GO:0071253) |
2.1 | 6.2 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
2.1 | 4.1 | GO:0042281 | dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity(GO:0042281) |
2.0 | 8.2 | GO:0005042 | netrin receptor activity(GO:0005042) |
2.0 | 55.1 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
2.0 | 8.1 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
2.0 | 10.0 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
2.0 | 25.9 | GO:0050811 | GABA receptor binding(GO:0050811) |
2.0 | 5.9 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
2.0 | 39.4 | GO:0003785 | actin monomer binding(GO:0003785) |
2.0 | 7.9 | GO:0046870 | cadmium ion binding(GO:0046870) |
1.9 | 13.5 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
1.9 | 7.7 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
1.9 | 68.0 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
1.8 | 16.4 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
1.8 | 7.3 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
1.8 | 9.1 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
1.8 | 8.9 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
1.8 | 7.0 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
1.8 | 5.3 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
1.7 | 7.0 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
1.7 | 25.8 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
1.7 | 5.1 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
1.7 | 6.8 | GO:1904288 | BAT3 complex binding(GO:1904288) |
1.7 | 6.8 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
1.7 | 18.5 | GO:0001223 | transcription coactivator binding(GO:0001223) |
1.7 | 25.2 | GO:0022840 | leak channel activity(GO:0022840) narrow pore channel activity(GO:0022842) |
1.7 | 14.9 | GO:0103116 | alpha-D-galactofuranose transporter activity(GO:0103116) |
1.6 | 6.5 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
1.6 | 6.5 | GO:0008502 | melatonin receptor activity(GO:0008502) |
1.6 | 6.5 | GO:0001642 | group III metabotropic glutamate receptor activity(GO:0001642) |
1.6 | 4.7 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
1.6 | 4.7 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
1.6 | 3.1 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
1.5 | 4.6 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
1.5 | 7.7 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
1.5 | 1.5 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
1.5 | 3.1 | GO:0097016 | L27 domain binding(GO:0097016) |
1.5 | 4.5 | GO:0050145 | nucleoside phosphate kinase activity(GO:0050145) |
1.5 | 25.3 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
1.5 | 33.6 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
1.5 | 17.5 | GO:0031402 | sodium ion binding(GO:0031402) |
1.5 | 11.6 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
1.4 | 4.3 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
1.4 | 5.8 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
1.4 | 4.3 | GO:0004470 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) |
1.4 | 41.0 | GO:0001540 | beta-amyloid binding(GO:0001540) |
1.4 | 36.1 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
1.4 | 36.7 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
1.3 | 1.3 | GO:0016508 | long-chain-enoyl-CoA hydratase activity(GO:0016508) |
1.3 | 5.4 | GO:0015375 | glycine:sodium symporter activity(GO:0015375) |
1.3 | 6.7 | GO:1990254 | keratin filament binding(GO:1990254) |
1.3 | 21.1 | GO:0016917 | GABA receptor activity(GO:0016917) |
1.3 | 1.3 | GO:0016743 | carboxyl- or carbamoyltransferase activity(GO:0016743) |
1.3 | 9.1 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
1.3 | 3.9 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
1.3 | 27.1 | GO:0071837 | HMG box domain binding(GO:0071837) |
1.3 | 11.6 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
1.3 | 2.6 | GO:0001030 | RNA polymerase III type 1 promoter DNA binding(GO:0001030) RNA polymerase III type 2 promoter DNA binding(GO:0001031) RNA polymerase III type 3 promoter DNA binding(GO:0001032) 5S rDNA binding(GO:0080084) |
1.3 | 15.3 | GO:0003905 | alkylbase DNA N-glycosylase activity(GO:0003905) DNA-3-methylbase glycosylase activity(GO:0043733) |
1.3 | 19.1 | GO:0030553 | cGMP binding(GO:0030553) |
1.3 | 3.8 | GO:0034711 | inhibin binding(GO:0034711) |
1.3 | 23.8 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
1.3 | 3.8 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
1.3 | 22.5 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
1.2 | 8.7 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
1.2 | 3.7 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
1.2 | 14.5 | GO:0015026 | coreceptor activity(GO:0015026) |
1.2 | 6.0 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
1.2 | 7.2 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
1.2 | 3.6 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
1.2 | 3.5 | GO:0055100 | adiponectin binding(GO:0055100) |
1.2 | 5.8 | GO:0004854 | xanthine dehydrogenase activity(GO:0004854) oxidoreductase activity, acting on CH or CH2 groups, NAD or NADP as acceptor(GO:0016726) |
1.1 | 3.4 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
1.1 | 10.3 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
1.1 | 3.4 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
1.1 | 12.4 | GO:0048018 | receptor agonist activity(GO:0048018) |
1.1 | 3.4 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
1.1 | 4.4 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
1.1 | 7.6 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
1.1 | 3.2 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
1.1 | 5.3 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
1.1 | 18.0 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
1.1 | 59.3 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
1.1 | 5.3 | GO:0070051 | fibrinogen binding(GO:0070051) |
1.0 | 8.3 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
1.0 | 22.7 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
1.0 | 2.1 | GO:0042289 | MHC class II protein binding(GO:0042289) |
1.0 | 22.5 | GO:0046875 | ephrin receptor binding(GO:0046875) |
1.0 | 11.2 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
1.0 | 4.1 | GO:0098634 | protein binding involved in cell-matrix adhesion(GO:0098634) |
1.0 | 4.1 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
1.0 | 6.1 | GO:0022858 | L-alanine transmembrane transporter activity(GO:0015180) alanine transmembrane transporter activity(GO:0022858) |
1.0 | 3.0 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
1.0 | 52.5 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
1.0 | 3.9 | GO:0016018 | cyclosporin A binding(GO:0016018) |
1.0 | 4.8 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
1.0 | 15.3 | GO:0008373 | sialyltransferase activity(GO:0008373) |
1.0 | 4.8 | GO:0031628 | opioid receptor binding(GO:0031628) |
1.0 | 2.9 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
1.0 | 2.9 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.9 | 10.9 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.9 | 3.6 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.9 | 2.7 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
0.9 | 4.5 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.9 | 8.1 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.9 | 15.1 | GO:0005112 | Notch binding(GO:0005112) |
0.9 | 3.5 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.9 | 7.0 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
0.9 | 2.6 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.9 | 5.2 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.9 | 2.6 | GO:0035851 | Krueppel-associated box domain binding(GO:0035851) |
0.9 | 5.2 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
0.9 | 5.1 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.8 | 4.2 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.8 | 16.2 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.8 | 4.8 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
0.8 | 2.4 | GO:0030957 | Tat protein binding(GO:0030957) |
0.8 | 12.5 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.8 | 10.8 | GO:0099589 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.8 | 3.8 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.7 | 2.2 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.7 | 2.1 | GO:0008495 | 4-hydroxybenzoate octaprenyltransferase activity(GO:0008412) protoheme IX farnesyltransferase activity(GO:0008495) (S)-2,3-di-O-geranylgeranylglyceryl phosphate synthase activity(GO:0043888) cadaverine aminopropyltransferase activity(GO:0043918) agmatine aminopropyltransferase activity(GO:0043919) 1,4-dihydroxy-2-naphthoate octaprenyltransferase activity(GO:0046428) trans-pentaprenyltranstransferase activity(GO:0048045) ATP dimethylallyltransferase activity(GO:0052622) ADP dimethylallyltransferase activity(GO:0052623) |
0.7 | 0.7 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.7 | 6.3 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.7 | 1.4 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
0.7 | 2.1 | GO:0030375 | thyroid hormone receptor coactivator activity(GO:0030375) |
0.7 | 16.0 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.7 | 2.1 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.7 | 6.2 | GO:0098599 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.7 | 2.1 | GO:2001069 | glycogen binding(GO:2001069) |
0.7 | 3.5 | GO:0000832 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
0.7 | 2.0 | GO:0070840 | dynein complex binding(GO:0070840) |
0.7 | 4.7 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.7 | 2.0 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.7 | 1.3 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.6 | 14.9 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.6 | 3.9 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.6 | 2.6 | GO:0098988 | G-protein coupled glutamate receptor activity(GO:0098988) |
0.6 | 7.7 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.6 | 1.9 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.6 | 1.9 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
0.6 | 6.2 | GO:0022821 | sodium:proton antiporter activity(GO:0015385) potassium:proton antiporter activity(GO:0015386) potassium ion antiporter activity(GO:0022821) |
0.6 | 7.4 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.6 | 11.1 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.6 | 4.3 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.6 | 0.6 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.6 | 7.7 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.6 | 6.3 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.6 | 10.6 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.6 | 4.4 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.5 | 2.2 | GO:0043842 | Kdo transferase activity(GO:0043842) |
0.5 | 1.6 | GO:0004174 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.5 | 3.8 | GO:0102338 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.5 | 2.1 | GO:0031544 | peptidyl-proline 3-dioxygenase activity(GO:0031544) |
0.5 | 1.6 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
0.5 | 2.1 | GO:0000403 | Y-form DNA binding(GO:0000403) |
0.5 | 14.3 | GO:0035254 | glutamate receptor binding(GO:0035254) |
0.5 | 4.7 | GO:0032041 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
0.5 | 5.2 | GO:0005234 | extracellular-glutamate-gated ion channel activity(GO:0005234) |
0.5 | 2.6 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) |
0.5 | 13.7 | GO:0019894 | kinesin binding(GO:0019894) |
0.5 | 1.0 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.5 | 1.5 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.5 | 3.0 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
0.5 | 1.9 | GO:0034584 | piRNA binding(GO:0034584) |
0.5 | 3.9 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.5 | 12.0 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.5 | 1.0 | GO:0004359 | glutaminase activity(GO:0004359) |
0.5 | 5.2 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.5 | 1.4 | GO:0004690 | cyclic nucleotide-dependent protein kinase activity(GO:0004690) |
0.5 | 1.4 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) |
0.5 | 1.9 | GO:0015368 | calcium:cation antiporter activity(GO:0015368) |
0.5 | 4.2 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.5 | 1.4 | GO:0016015 | morphogen activity(GO:0016015) |
0.5 | 3.6 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.4 | 1.8 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.4 | 4.3 | GO:0031404 | chloride ion binding(GO:0031404) |
0.4 | 7.3 | GO:0042923 | neuropeptide binding(GO:0042923) |
0.4 | 1.7 | GO:0045545 | syndecan binding(GO:0045545) |
0.4 | 1.3 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.4 | 1.3 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.4 | 0.4 | GO:0050693 | LBD domain binding(GO:0050693) |
0.4 | 20.4 | GO:0008378 | galactosyltransferase activity(GO:0008378) |
0.4 | 2.8 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.4 | 1.2 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.4 | 7.4 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.4 | 4.5 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.4 | 1.5 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.4 | 1.5 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.4 | 2.2 | GO:0016724 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.4 | 3.2 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
0.3 | 2.8 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.3 | 2.1 | GO:0033691 | sialic acid binding(GO:0033691) |
0.3 | 31.4 | GO:0008201 | heparin binding(GO:0008201) |
0.3 | 8.9 | GO:0052771 | coenzyme F390-A hydrolase activity(GO:0052770) coenzyme F390-G hydrolase activity(GO:0052771) |
0.3 | 5.1 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.3 | 14.0 | GO:0004027 | alcohol sulfotransferase activity(GO:0004027) |
0.3 | 6.4 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.3 | 0.7 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
0.3 | 6.7 | GO:0030332 | cyclin binding(GO:0030332) |
0.3 | 4.3 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.3 | 5.8 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.3 | 2.9 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.3 | 6.9 | GO:0051990 | (R)-2-hydroxyglutarate dehydrogenase activity(GO:0051990) |
0.3 | 0.9 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.3 | 0.9 | GO:0015226 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
0.3 | 2.1 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.3 | 1.8 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) |
0.3 | 2.9 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.3 | 10.5 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.3 | 1.4 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.3 | 12.9 | GO:0008907 | integrase activity(GO:0008907) T/G mismatch-specific endonuclease activity(GO:0043765) retroviral integrase activity(GO:0044823) retroviral 3' processing activity(GO:0044824) |
0.3 | 0.3 | GO:0032356 | oxidized DNA binding(GO:0032356) oxidized purine DNA binding(GO:0032357) |
0.3 | 1.1 | GO:0018812 | 3-hydroxyacyl-CoA dehydratase activity(GO:0018812) |
0.3 | 1.6 | GO:0070191 | methionine-R-sulfoxide reductase activity(GO:0070191) |
0.3 | 4.3 | GO:0016503 | pheromone receptor activity(GO:0016503) |
0.3 | 1.3 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.3 | 1.5 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.2 | 1.2 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.2 | 2.4 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.2 | 2.4 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
0.2 | 0.5 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.2 | 5.8 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.2 | 2.8 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.2 | 0.9 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.2 | 7.0 | GO:1990782 | protein tyrosine kinase binding(GO:1990782) |
0.2 | 0.9 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.2 | 1.3 | GO:0072349 | modified amino acid transmembrane transporter activity(GO:0072349) |
0.2 | 0.9 | GO:0033765 | steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) |
0.2 | 0.6 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.2 | 1.1 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.2 | 3.1 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
0.2 | 4.0 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.2 | 1.0 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.2 | 1.7 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.2 | 2.1 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.2 | 1.8 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.2 | 0.9 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.2 | 0.9 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.2 | 0.5 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.2 | 0.3 | GO:0031748 | D1 dopamine receptor binding(GO:0031748) |
0.2 | 3.1 | GO:0070888 | E-box binding(GO:0070888) |
0.2 | 0.3 | GO:0042895 | antibiotic transporter activity(GO:0042895) |
0.2 | 0.6 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.2 | 0.5 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.2 | 0.2 | GO:0030172 | troponin C binding(GO:0030172) |
0.2 | 0.5 | GO:0004096 | catalase activity(GO:0004096) |
0.2 | 0.5 | GO:0004793 | threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
0.1 | 1.4 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.1 | 0.4 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.1 | 0.9 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.1 | 0.3 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.1 | 26.1 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
0.1 | 0.4 | GO:0004955 | prostaglandin receptor activity(GO:0004955) |
0.1 | 0.1 | GO:0051378 | serotonin binding(GO:0051378) |
0.1 | 0.1 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
0.1 | 0.1 | GO:0001224 | RNA polymerase II transcription cofactor binding(GO:0001224) RNA polymerase II transcription corepressor binding(GO:0001226) |
0.1 | 0.5 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.1 | 0.1 | GO:0001016 | RNA polymerase III regulatory region DNA binding(GO:0001016) |
0.1 | 1.3 | GO:0030552 | cAMP binding(GO:0030552) |
0.1 | 0.3 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.1 | 0.4 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.1 | 0.1 | GO:0005283 | sodium:amino acid symporter activity(GO:0005283) |
0.1 | 0.2 | GO:0035877 | death effector domain binding(GO:0035877) |
0.1 | 0.5 | GO:0015643 | toxic substance binding(GO:0015643) |
0.1 | 0.8 | GO:0055103 | ligase regulator activity(GO:0055103) |
0.1 | 0.1 | GO:0019959 | interleukin-8 binding(GO:0019959) |
0.1 | 0.2 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
0.1 | 0.4 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.0 | 2.6 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.0 | 0.1 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.0 | 0.0 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
0.0 | 1.3 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
0.0 | 0.0 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
0.0 | 0.1 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.0 | 0.0 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
0.0 | 0.1 | GO:0004982 | N-formyl peptide receptor activity(GO:0004982) |
0.0 | 0.1 | GO:0004556 | alpha-amylase activity(GO:0004556) |
0.0 | 0.0 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.0 | 0.0 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.0 | 0.1 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.0 | 0.0 | GO:0004376 | glycolipid mannosyltransferase activity(GO:0004376) |
0.0 | 7.4 | GO:0005549 | odorant binding(GO:0005549) |
0.0 | 0.2 | GO:0004526 | ribonuclease P activity(GO:0004526) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.0 | 63.4 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
2.3 | 74.5 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
2.2 | 28.5 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
2.1 | 62.6 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
1.7 | 40.9 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
1.5 | 24.6 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
1.5 | 51.9 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
1.4 | 24.3 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
1.4 | 29.7 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
1.3 | 21.2 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
1.3 | 7.6 | ST G ALPHA I PATHWAY | G alpha i Pathway |
1.1 | 27.2 | PID EPHA FWDPATHWAY | EPHA forward signaling |
1.1 | 35.1 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
1.0 | 20.5 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.9 | 18.5 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.8 | 0.8 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
0.8 | 7.3 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.8 | 12.1 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.8 | 2.3 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.8 | 8.4 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.6 | 11.4 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.6 | 1.3 | PID REELIN PATHWAY | Reelin signaling pathway |
0.6 | 0.6 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.6 | 0.6 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.5 | 2.2 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.5 | 1.9 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.4 | 6.2 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.4 | 1.6 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.4 | 9.8 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.4 | 2.3 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.4 | 3.3 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.3 | 4.2 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.3 | 4.4 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.3 | 0.3 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.3 | 1.0 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.3 | 8.7 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.2 | 0.2 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.2 | 1.4 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.2 | 0.8 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.2 | 4.5 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.2 | 2.6 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.1 | 6.3 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.1 | 1.0 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.1 | 18.8 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.1 | 6.0 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.1 | 1.2 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
0.1 | 0.7 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.1 | 0.5 | PID ALK2 PATHWAY | ALK2 signaling events |
0.1 | 3.3 | NABA COLLAGENS | Genes encoding collagen proteins |
0.1 | 17.8 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.1 | 0.8 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.1 | 0.2 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.1 | 1.9 | PID LKB1 PATHWAY | LKB1 signaling events |
0.0 | 0.1 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.0 | 0.0 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.0 | 0.0 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.0 | 0.1 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
9.9 | 139.1 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
6.4 | 12.9 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
5.6 | 5.6 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
4.2 | 46.1 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
3.5 | 3.5 | REACTOME SHC1 EVENTS IN EGFR SIGNALING | Genes involved in SHC1 events in EGFR signaling |
3.4 | 72.0 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
3.4 | 64.5 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
2.6 | 18.4 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
2.6 | 25.8 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
2.5 | 42.8 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
2.5 | 47.0 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
2.5 | 2.5 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
2.5 | 4.9 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
2.3 | 9.3 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
2.3 | 18.4 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
2.1 | 24.8 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
2.0 | 22.4 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
2.0 | 17.8 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
1.9 | 48.7 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
1.8 | 24.0 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
1.8 | 20.3 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
1.8 | 41.3 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
1.7 | 20.2 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
1.6 | 8.0 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
1.6 | 33.0 | REACTOME SIGNALLING TO RAS | Genes involved in Signalling to RAS |
1.5 | 62.8 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
1.5 | 1.5 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
1.5 | 20.6 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
1.5 | 4.4 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
1.4 | 11.6 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
1.4 | 31.3 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
1.3 | 2.7 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
1.3 | 3.9 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
1.2 | 9.4 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
1.2 | 8.2 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
1.1 | 3.4 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
1.1 | 17.7 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
1.1 | 24.1 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
1.1 | 27.6 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
1.1 | 11.6 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
1.0 | 15.5 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
1.0 | 22.6 | REACTOME KINESINS | Genes involved in Kinesins |
1.0 | 16.3 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
1.0 | 12.1 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
1.0 | 1.0 | REACTOME TGF BETA RECEPTOR SIGNALING ACTIVATES SMADS | Genes involved in TGF-beta receptor signaling activates SMADs |
1.0 | 8.8 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
1.0 | 11.6 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
1.0 | 7.7 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.9 | 8.8 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.9 | 8.7 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.9 | 14.5 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.8 | 24.6 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.8 | 7.0 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.7 | 5.2 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.7 | 11.0 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.7 | 3.5 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |
0.7 | 11.2 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.7 | 13.1 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.6 | 5.8 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.6 | 0.6 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
0.6 | 7.1 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.6 | 1.8 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.6 | 6.3 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.6 | 23.1 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.6 | 19.1 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.6 | 20.1 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.5 | 10.3 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.5 | 6.4 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.5 | 17.0 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.5 | 6.7 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.5 | 22.7 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.4 | 0.4 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.4 | 9.3 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.4 | 3.0 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.4 | 0.7 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.3 | 0.6 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
0.3 | 5.4 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.3 | 2.9 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.3 | 1.8 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.2 | 2.0 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.2 | 2.9 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.2 | 1.2 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.2 | 1.9 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.2 | 1.8 | REACTOME ION CHANNEL TRANSPORT | Genes involved in Ion channel transport |
0.2 | 1.0 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.2 | 6.6 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.2 | 2.0 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.2 | 3.0 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.2 | 1.7 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.1 | 2.5 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.1 | 0.7 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.1 | 3.7 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.1 | 0.2 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.1 | 0.1 | REACTOME NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Neurotransmitter Release Cycle |
0.1 | 4.2 | REACTOME L1CAM INTERACTIONS | Genes involved in L1CAM interactions |
0.1 | 0.3 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.1 | 1.2 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.1 | 1.1 | REACTOME FORMATION OF THE HIV1 EARLY ELONGATION COMPLEX | Genes involved in Formation of the HIV-1 Early Elongation Complex |
0.0 | 0.5 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.0 | 0.1 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.0 | 0.7 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.0 | 0.4 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.0 | 0.1 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.0 | 0.2 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.0 | 0.0 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.0 | 0.0 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |